1. Introduction {#sec1-pathogens-09-00176}
===============

Among hematophagous arthropods, ticks transmit the greatest variety of pathogens of public health and veterinary importance whose incidence is growing worldwide \[[@B1-pathogens-09-00176]\]. The French West Indies, including the islands of Guadeloupe and Martinique, are located in the heart of the Caribbean Neotropical zone, a cosmopolitan area characterized by a tropical climate, intercontinental trade and animal movements (legal and illegal trade as well as bird migration) that are favorable for the introduction and spread of ticks and tick-borne pathogens (TBPs) \[[@B2-pathogens-09-00176]\]. Yet, the epidemiological situation of the Caribbean area with regard to the diversity of tick species and tick-borne diseases (TBDs) is poorly documented \[[@B3-pathogens-09-00176]\].

*Amblyomma variegatum, Rhipicephalus microplus* and *Rhipicephalis sanguineus* sensu lato are the main tick species found in the French Antilles that are involved in the transmission of TBPs of medical and veterinary importance \[[@B3-pathogens-09-00176]\]. While *Rhipicephalis sanguineus* sensu lato are mainly found infesting dogs, *Amblyomma variegatum*, also known as the tropical bont tick (TBT) in the Caribbean, and *Rhipicephalus microplus* (the "cattle tick") have been the two main tropical livestock pests since their introduction in the Caribbean through imports of infested animals from Africa and Asia in the 18th--19th centuries \[[@B3-pathogens-09-00176],[@B4-pathogens-09-00176],[@B5-pathogens-09-00176],[@B6-pathogens-09-00176],[@B7-pathogens-09-00176],[@B8-pathogens-09-00176],[@B9-pathogens-09-00176]\].

*R. microplus*, a one-host tick highly specific to cattle, is mainly involved in the transmission of *Anaplasma marginale*, *Babesia bovis* and *Babesia bigemina*, causing bovine anaplasmosis and babesiosis, respectively. These endemic pathogens are responsible for important economic loss to farming industries in the Caribbean and are still a sanitary threat \[[@B7-pathogens-09-00176],[@B10-pathogens-09-00176]\].

*A. variegatum* is a three-host tick species, with immature stages that can parasitize a wide range of hosts, including rodents, mongooses and birds, as well as an adult stage that is more specific to cattle \[[@B11-pathogens-09-00176]\]. This tick species is mainly involved in *Ehrlichia ruminantium* transmission, the causative agent of heartwater, a fatal ruminant ehrlichiosis. Although *A. variegatum* is present in both Martinique (mainly in the south) and Guadeloupe (widespread), *E. ruminantium* has only been reported in Guadeloupe \[[@B12-pathogens-09-00176]\]. In addition, *A. variegatum* ticks are also a vector of *Rickettsia africae*, which is common in the Caribbean and can induce human rickettsiosis, called African tick-bite fever \[[@B9-pathogens-09-00176],[@B13-pathogens-09-00176],[@B14-pathogens-09-00176]\]. African tick-bite fever remains a concern mainly for travelers. Indeed, despite high levels of tick infection and seroprevalence in human and cattle sera, only two human cases of African tick-bite fever have been reported to date, only in travelers returning from Guadeloupe \[[@B9-pathogens-09-00176],[@B15-pathogens-09-00176]\]. Lastly, *A. variegatum* is also involved in the epidemiology of *Theileria mutans* and *Theileria velifera*, two cattle parasites with low and no virulence, respectively \[[@B6-pathogens-09-00176],[@B8-pathogens-09-00176]\]. However, very few information is available on the distribution and prevalence of these two Apicomplexa in the Caribbean.

Most of the epidemiological data available did not survey or determine the diversity of TBPs circulating in the Caribbean, since they were often limited to the detection of some well-known pathogens, via serological studies in animals or humans, or on molecular biology testing (PCR, nested PCR) \[[@B16-pathogens-09-00176],[@B17-pathogens-09-00176]\]. Thus, regarding the lack of recent information and the limited extent of the epidemiological data available, new insight into the epidemiology of ticks and TBPs was needed to better address the prevalence and (re)emergence of TBDs in the Caribbean.

In order to improve the surveillance ability of tick-borne pathogens in the Neotropical area, we implemented a new large-scale screening tool based on a microfluidic real-time PCR approach. Microfluidic real-time PCR is based on the use of microfluidic chips allowing the performance of up to 9216 individual PCR reactions per run, and thus the simultaneous detection of up to 96 targets in up to 96 samples. The recent development and use of a microfluidic real-time PCR for the rapid and concomitant detection of a large panel of TBPs in European ticks has paved the way for promising and broader surveillance capacities \[[@B18-pathogens-09-00176],[@B19-pathogens-09-00176],[@B20-pathogens-09-00176],[@B21-pathogens-09-00176],[@B22-pathogens-09-00176]\]. Here, we adapted and designed a new microfluidic real-time PCR system suited to the simultaneous screening of the main bacteria and protozoans potentially transmitted by ticks in the Caribbean. Not only did the system enable the direct detection of 49 bacterial and parasitic species, but it also enabled, within a single experiment, broader capacities for the surveillance of potentially pathogenic microorganisms by targeting the main bacterial and protozoan genera involved in human and animal vector-borne diseases (one protozoan phylum and eight bacterial and protozoan genera). In addition, the system enabled the molecular identification of the three well-known tick species involved in TBDs in the Caribbean in order to confirm the morphological tick species identification determined on the field. Finally, we used the new high-throughput detection tool to conduct large-scale screening of TBPs in 132 *A. variegatum* and 446 *R. microplus* adult specimens collected in Guadeloupe and Martinique. We demonstrated the system's ability to detect well-known TBPs occurring in the French West Indies, as well as unsuspected TBPs and potential new microorganisms. This new method can considerably improve the ability to monitor emerging and non-emerging TBPs through large-scale surveys in the Caribbean area.

2. Results {#sec2-pathogens-09-00176}
==========

2.1. Implementation of the High-Throughput Microfluidic Real-Time PCR System for Tick-Borne Pathogen Screening {#sec2dot1-pathogens-09-00176}
--------------------------------------------------------------------------------------------------------------

The high-throughput microfluidic real-time PCR system developed for the screening of known and potential TBPs in Caribbean ticks included 61 sets of primers and probes. Among them, 49 designs were developed for the detection of bacterial (n = 32) and protozoan (n = 17) species and bacterial (n = 5) and protozoan (n = 3) genera/phyla ([Table 1](#pathogens-09-00176-t001){ref-type="table"}). Three sets of primers and probes were developed for the molecular identification of the three tick species found in the Caribbean: *A. variegatum*, *R. microplus* and *R. sanguineus* sensu lato ([Table 1](#pathogens-09-00176-t001){ref-type="table"}). Lastly, we developed a design targeting a conserved region of the 16S rRNA genes in ticks, called "Tick spp.", used as a control for DNA/RNA extraction ([Table 1](#pathogens-09-00176-t001){ref-type="table"}).

The detection ability of each design and the effect of pre-amplification on detection signals were first checked by TaqMan real-time PCR on a LightCycler 480 apparatus using a range of dilutions of positive controls ([Table 1](#pathogens-09-00176-t001){ref-type="table"}, [Table S1](#app1-pathogens-09-00176){ref-type="app"}). Three kinds of positive controls were used, including bacterial or protozoan cultures when available, DNA from infected ticks or blood samples, and plasmidic constructions as a last resort ([Table 1](#pathogens-09-00176-t001){ref-type="table"}). Except for the design targeting Borrelia burgdorferi sensu stricto, which never succeeded in detecting the positive controls even after a pre-amplification step, the remaining 60 designs targeting TBPs and tick species were able to detect their target with Ct values between 6 and 38 (data not shown). Pre-amplification improved the quality of detection and was, therefore, validated as part of the screening protocol (see [Figure S1](#app1-pathogens-09-00176){ref-type="app"}). The relative specificity of the 61 designs was then evaluated using the BioMark system and a total of 62 positive controls ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}, [Table S1](#app1-pathogens-09-00176){ref-type="app"}).

Forty-three primer/probe sets were able to specifically detect and amplify their target using a Ct cut-off value of 30; they were then directly validated ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}). The remaining designs were able to detect and amplify their target, but they also gave positive results in outgroup controls. Interestingly, two kinds of unsuspected signals were observed: some were related to cross-reactions with closely related species and some to potential co-infections in controls corresponding to field samples ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}). Thus, eight designs---*Rickettsia massiliae*, *Rickettsia conorii*, *Bartonella henselae*, *Bartonella bacilliformis*, *Babesia canis vogeli*, *Babesia microti*, *Theileria parva* and *Hepatozoon americanum*---gave positive results in outgroup controls, revealing cross-reactions with one to two closely related species ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}). Caution will be required when interpreting results obtained with these designs. Seven designs---*Rickettsia* spp., *Rickettsia felis*, *Rickettsia africae*, *Apicomplexa*, *Babesia bigemina*, *Hepatozoon* spp. and *Hepatozoon canis*---gave positive results in outgroup controls linked to potential co-infection in controls corresponding to DNA from infected ticks or blood samples ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}). As co-infections may occur in natural tick or blood samples, these unexpected detections in biological samples were likely due to the natural (co)occurrence of microorganisms rather than to cross-reactions. Finally, the *Babesia ovis* and *Rickettsia rickettsii* designs gave multiple cross-reactions with closely related species or distant outgroups and, thus, were considered as non-specific and removed from the rest of the study ([Figure 1](#pathogens-09-00176-f001){ref-type="fig"}). More details on the relative specificity analysis of the designs are available in [Appendix A](#app2-pathogens-09-00176){ref-type="app"}.

To conclude, with the exception of the sets of primers and probes targeting *Borrelia burgdorferi* sensu stricto, *Babesia ovis* and *Rickettsia rickettsii* that were ultimately removed from the study, the 58 remaining designs were validated for the high-throughput screening of pathogens in Caribbean ticks, taking into account the notified cross-reactions.

2.2. Large-Scale TBP Detection Survey in Ticks from Guadeloupe and Martinique {#sec2dot2-pathogens-09-00176}
-----------------------------------------------------------------------------

A total of 578 adult ticks were collected from cattle in Guadeloupe and Martinique. In total, 523 samples were tested using the BioMarkTM system developed in this study. The molecular identification of *Amblyomma variegatum* and *Rhipicephalus microplus* using the corresponding specific designs were consistent with the morphological identification made after tick collection. The number of positive ticks and the corresponding infection rates for each detected pathogen were calculated for 132 *A. variegatum* as well as 165 and 281 *R. microplus* specimens from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). As some of the *R. microplus* samples corresponded to pools of two to four adult specimens, we reported the minimum and maximum infection rates (see Materials and Methods).

Conventional PCRs/nested PCRs followed by amplicon sequencing were performed on several tick samples presenting low Ct values to confirm the results of the newly designed BioMark^TM^ system (see Materials and Methods section). Identity percentages of the sequences obtained with reference sequences available in GenBank (NCBI) are presented in [Table 2](#pathogens-09-00176-t002){ref-type="table"}.

### 2.2.1. Detection of Known TBPs in Caribbean Ticks {#sec2dot2dot1-pathogens-09-00176}

Seven TBPs known to circulate in the Caribbean were detected in ticks from Guadeloupe and Martinique: *R. africae*, *E. ruminantium*, *A. marginale*, *B. bigemina*, *B. bovis*, *T. mutans* and *T. velifera* ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}).

*Rickettsia* spp. were only detected in ticks collected in Guadeloupe ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). *R. africae* was identified in 95.5% of the *A. variegatum* samples ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). In contrast, *Rickettsia* spp. detected in 15.2%--23% of the *R. microplus* samples from Guadeloupe were not directly identified as *R. africae* with the BioMark^TM^ system ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). Thus, 14 *A. variegatum* (6/14) and *R. microplus* (8/14) samples positive for *Rickettsia* spp. were tested by nested PCR with primers targeting the ompB gene; this was followed by sequencing. All the sequences recovered were identical and displayed 100% identity with *R. africae*, confirming that the *Rickettsia* spp. detected in *R. microplus* from Guadeloupe corresponded also to *R. africae*. ([Table 2](#pathogens-09-00176-t002){ref-type="table"}). The consensus sequence was deposited under the name *Rickettsia africae* Tick208 (accession number MK049851).

*E. ruminantium* was identified in 5.3% of the *A. variegatum* ticks from Guadeloupe ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We confirmed the presence of *E. ruminantium* nucleic acids by testing one sample of *A. variegatum* by conventional PCR targeting the 16S rRNA genes; this was followed by amplicon sequencing. The sequence obtained displayed 100% sequence identity with *E. ruminantium* and was deposited under the name *Ehrlichia ruminantium* Tick116 (accession number MK049848) ([Table 2](#pathogens-09-00176-t002){ref-type="table"}).

*A. marginale* was identified in *R. microplus* ticks from both islands, with infection rates reaching 3%--4.2% and 39.9%--41.3% of specimens from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We confirmed the detection of *A. marginale* by testing two samples of *R. microplus* by conventional PCR targeting the 16S rRNA genes; this was followed by amplicon sequencing. We obtained two identical sequences, deposited under the name *Anaplasma* sp. Tick283 (accession number MK049844), which displayed 100% sequence identity with *Anaplasma* spp. including *A. marginale* ([Table 2](#pathogens-09-00176-t002){ref-type="table"}).

*B. bigemina* was detected in 0.6%--1.2% and 12.5%--12.8% of the *R. microplus* ticks from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). *B. bovis* was only detected in ticks from Martinique, with an infection rate of 0.7% in *R. microplus* samples ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). As conventional and nested PCR did not succeed in detecting these parasites, we directly sequenced amplicons obtained with the *B. bigemina* and *B. bovis* designs developed here, and corresponding sequences were identified (accession numbers MK071738 and MK071739 respectively) ([Table 2](#pathogens-09-00176-t002){ref-type="table"}).

*T. velifera* and *T. mutans* were detected in both tick species and on both islands. *T. velifera* was identified in 42.3% of the *A. variegatum* samples and in 23.6%--31.5% and 25.6%--26% of the *R. microplus* samples from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). Moreover, *T. mutans* was detected in 1.5% of the *A. variegatum* samples and in 1.8%--2.4% and 1.4% of the *R. microplus* samples from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). Unfortunately, neither conventional PCR nor BioMark amplicon sequencing succeeded in confirming the BioMark results.

### 2.2.2. Detection of Unexpected Microorganisms in Caribbean Ticks {#sec2dot2dot2-pathogens-09-00176}

Unexpected signals were obtained during the screening of microorganisms in ticks from Guadeloupe and Martinique, including the first detection of untargeted species belonging to the genera *Anaplasma*, *Ehrlichia*, *Borrelia* and *Leishmania* ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}).

*Ehrlichia* spp. were detected in *R. microplus* ticks from both islands, with infection rates reaching 4.2%--6.6% and 47.7%--49.1% in Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We tested two of the *Ehrlichia* spp.-positive *R. microplus* samples by conventional PCR targeting the 16S rRNA genes in order to identify the *Ehrlichia* spp. present in the Caribbean sample. We obtained two identical sequences, deposited under the name *Ehrlichia* sp. Tick428 (accession number MK049849) ([Table 2](#pathogens-09-00176-t002){ref-type="table"}). Phylogenetic and genetic distance analyses were performed using a portion of the 16S rRNA genes of several *Ehrlichia* species ([Figure 3](#pathogens-09-00176-f003){ref-type="fig"}). The *Ehrlichia* sp. Tick428 sequence was found within a cluster including various uncharacterized *Ehrlichia* species detected in ticks from Asia and Africa ([Figure 3](#pathogens-09-00176-f003){ref-type="fig"}).

In addition, in around 50% (at least 4/8 ticks) and 18% (at least 22/114 ticks) of the *R. microplus* specimens positive for *Anaplasma* spp., none of the *Anaplasma* species targeted by the BioMark^TM^ system gave signals, suggesting the presence of an unexpected or new *Anaplasma* spp. ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We tested two of the *Anaplasma* spp.-positive *R. microplus* samples by conventional PCR targeting the 16S rRNA genes. We obtained two identical sequences, deposited under the name *Anaplasma* sp. Tick314 (accession number MK049845) ([Table 2](#pathogens-09-00176-t002){ref-type="table"}). This sequence displayed 100% sequence identity with *Candidatus* Anaplasma boleense. Phylogenetic and genetic distance analyses were performed using a portion of the 16S rRNA genes of several *Anaplasma* species ([Figure 4](#pathogens-09-00176-f004){ref-type="fig"}). The *Anaplasma* sp. Tick314 sequence was found in a cluster including *Candidatus* Anaplasma boleense, *Anaplasma platys* and *Anaplasma phagocytophilum*.

*Borrelia* spp. were detected in both tick species from both islands ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). Infection rates reached 5.3% in *A. variegatum* and 0.6% and 4.3% in *R. microplus* from Guadeloupe and Martinique, respectively ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). None of the specific targeted *Borrelia* species causing Lyme disease (*Borrelia burgdorferi* sensu lato), or the *Borrelia* relapsing fever group, gave any positive results, suggesting the occurrence of a new or unexpected *Borrelia* spp. in our samples ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We tested 30 of the *Borrelia* spp.-positive ticks by nested PCR targeting the flaB genes. Interestingly, we obtained two sequences according to the tick species analyzed. The *Borrelia* sp. Tick7 (accession number MK049846) sequence was recovered from one *A. variegatum* sample from Guadeloupe, and the *Borrelia* sp. Tick457 sequence (accession number MK049847) was recovered from four *R. microplus* samples from Martinique ([Table 2](#pathogens-09-00176-t002){ref-type="table"}). Phylogenetic and genetic distance analyses were performed using a portion of the flaB gene of several *Borrelia* species ([Figure 5](#pathogens-09-00176-f005){ref-type="fig"}). Surprisingly, the *Borrelia* sp. Tick7 sequence recovered from the *A. variegatum* sample, and found to be closely related to *B. anserina*, displayed an intermediate position, sharing homology with both the relapsing fever and Lyme disease groups ([Figure 5](#pathogens-09-00176-f005){ref-type="fig"}). Lastly, the *Borrelia* sp. Tick457 sequence recovered from the *R. microplus* samples confirmed the previous observations, forming a cluster with various relapsing fever *Borrelia* species encountered in hard ticks, including *B. lonestari* and *B. theileri* ([Figure 5](#pathogens-09-00176-f005){ref-type="fig"}).

Lastly, 0.7% of the *R. microplus* ticks from Martinique were positive for *Leishmania* spp. ([Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). We tested two of the *Leishmania* spp.-positive ticks by nested PCR targeting the small subunit rRNA gene. We obtained one sequence from one sample, deposited under the name *Leishmania martiniquensis* Tick389 (accession number MK049850) ([Table 2](#pathogens-09-00176-t002){ref-type="table"}). This sequence displayed 100% identity with both the *Leishmania martiniquensis* and *Leishmania siamensis* sequences ([Table 2](#pathogens-09-00176-t002){ref-type="table"}).

### 2.2.3. Co-Infections in Ticks in Guadeloupe and Martinique {#sec2dot2dot3-pathogens-09-00176}

We analyzed the co-infections observed in *Amblyomma variegatum* (n = 132 samples), *Rhipicephalus microplus* collected in Guadeloupe (n = 116 samples, including individual and pooled specimens) and Martinique (n = 275 samples, including individual and pooled specimens). In Guadeloupe, almost all of the *A. variegatum* samples (99.2%) were infected with at least one pathogen, whereas only 56% of the *R. microplus* samples were infected ([Figure 6](#pathogens-09-00176-f006){ref-type="fig"}, [Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). In contrast, 81% of the *R. microplus* from Martinique were infected with at least one pathogen ([Figure 6](#pathogens-09-00176-f006){ref-type="fig"}, [Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). High and similar percentages of the two tick species were infected with either one or two pathogens. The percentages drastically dropped for co-infection with three pathogens, with less than 10% of the ticks infected. Respectively one and nine *A. variegatum* and *R. microplus*, from Guadeloupe and Martinique, were co-infected with four pathogens, and one *R. microplus* from Martinique was found infected with five pathogens ([Figure 6](#pathogens-09-00176-f006){ref-type="fig"}, [Table A3](#pathogens-09-00176-t0A3){ref-type="table"}).

*A. variegatum* from Guadeloupe were find heavily infected by *R. africae,* yet it did not seem to affect the presence of other pathogen/microorganisms that were all found in co-infection with the bacteria ([Table A4](#pathogens-09-00176-t0A4){ref-type="table"}). Interestingly, in *R. microplus* from Guadeloupe, most of the single-infection reported corresponded to *R. africae* (12.9%) or *T. velifera* (21.6%) ([Table A5](#pathogens-09-00176-t0A5){ref-type="table"}). Positive association have been identified between *T. velifera* and *T. mutans*, and *Anaplasma* spp./*Borrelia* spp. ([Table A5](#pathogens-09-00176-t0A5){ref-type="table"}). Finally, in *R. microplus* from Martinique, five positive associations have been detected, including *T. mutans*/*T. velifera*, *T. mutans/Leishmania* spp., *T. mutans/Borrelia* spp., *T. velifera*/*B. bigemina* and *A. marginale*/*Ehrlichia* spp. ([Table A6](#pathogens-09-00176-t0A6){ref-type="table"}). The result of the co-occurrence test should be taken with caution and deserves further investigation regarding the few number of positive samples ([Table A5](#pathogens-09-00176-t0A5){ref-type="table"}, A6). Nevertheless, no exclusion seemed to occur between the pathogens/microorganisms detected in the two tick species from Guadeloupe and Martinique. More details on co-infections in ticks from Guadeloupe and Martinique are available in [Appendix B](#app3-pathogens-09-00176){ref-type="app"}.

3. Discussion {#sec3-pathogens-09-00176}
=============

In this study, a high-throughput microfluidic real-time PCR system based on the use of multiple primers/probes was developed for large-scale surveys of bacteria and protozoans potentially transmitted by ticks from the Caribbean area. The association of genus and species primer/probe designs targeting TBPs improved the technology's screening capacity, enabling not only the identification of infectious agents known to circulate in the studied area, but also the detection of unsuspected TBPs and new microorganisms belonging to the main bacterial and protozoan genera/phyla involved in TBDs worldwide. Nevertheless, as some endosymbiotic microorganisms may belong to known TBP genera, such as *Rickettsia* and *Coxiella*, confirmatory tests are required before suggesting the presence of a pathogenic microorganism \[[@B23-pathogens-09-00176],[@B24-pathogens-09-00176],[@B25-pathogens-09-00176]\]. When analyzing the specificity of the microfluidic real-time PCR system, cross-reactions were observed for some designs targeting closely related species; these must be taken into account when interpreting the results. Due to high design constraints and a lack of available sequences in public databases, the improvement of such cross-reacting oligonucleotides remains challenging. Here, the concomitant use of bacterial and protozoan genera can assist in identifying non-specific signals. In addition to detecting microorganisms, we developed sets of primers and probes enabling the molecular identification of the three main tick species involved in TBDs in the Caribbean: *A. variegatum*, *R. microplus* and *R. sanguineus* s.l. As the morphological identification of ticks collected in the field remains challenging, molecular identification can be used to confirm the identification of the tick species analyzed \[[@B16-pathogens-09-00176],[@B26-pathogens-09-00176],[@B27-pathogens-09-00176]\].

We used the newly developed high-throughput microfluidic real-time PCR system to perform an exploratory epidemiological study on TBPs and microorganisms potentially circulating in *A. variegatum* and *R. microplus* ticks collected on cattle in Guadeloupe and Martinique. The analysis provided an overview of the diversity of microorganisms belonging to the main bacterial and protozoan genera potentially transmitted by ticks. It enabled the detection both of known TBPs of public and animal health importance in the area that require surveillance and of unexpected microorganisms occurring in Caribbean ticks.

The four main pathogens responsible for ruminant diseases in the Caribbean, currently classified as notifiable diseases by the World Organization for Animal Health (OIE), have been detected by the microfluidic real-time PCR system. These are *E. ruminantium* in *A. variegatum* specimens and *A. marginale*, *B. bigemina* and *B. bovis* in *R. microplus*.

Interestingly, the *E. ruminantium* infection rate in *A. variegatum* reported in our study was much lower compared to in previous studies conducted between 2003 and 2005 in Guadeloupe (5.1% versus 36.7%) \[[@B12-pathogens-09-00176]\]. Although different study designs were used (different sampling strategies, study periods, detection methods, etc.), which may explain this difference, it would be worth further investigating whether the tick infection rate for *E. ruminantium* has decreased in Guadeloupe and possibly assessing the epidemiological impact in terms of the incidence and prevalence of heartwater in the ruminant population. These results are all the more surprising since systematic TBT surveillance and control programs have been discontinued in the French Antilles following the end of the POSEIDOM (Specific Options Program due to the remoteness and insularity of the overseas departments) eradication programs in 2006.

In this study, we have documented infection rates for *B. bigemina*, *B. bovis* and *A. marginale* in the *R. microplus* vector tick in the French West Indies for the first time. Indeed, records of such pathogens are mostly based on seroprevalence studies in cattle \[[@B7-pathogens-09-00176],[@B8-pathogens-09-00176],[@B10-pathogens-09-00176]\].

*R. microplus* ticks are both vectors and reservoirs of *B. bigemina* and *B. bovis*, transmitting the parasites transovarially and trans-stadially \[[@B28-pathogens-09-00176],[@B29-pathogens-09-00176]\]. As *R. microplus* ticks and cattle are both reservoirs of infection, the infection rates reported here seemed quite low. The life cycle of *Babesia* spp. requires complex interactions with its two hosts, which are the tick vector and the vertebrate host. The efficiency of tick acquisition and of transovarial and trans-stadial transmission of *B. bovis* and *B. bigemina* by *R. microplus*, involved in the long-term persistence of *Babesia* spp. in nature, is still poorly understood and warrants further investigations \[[@B28-pathogens-09-00176],[@B29-pathogens-09-00176]\].

Interestingly, *A. marginale* was detected in *R. microplus* from both islands, but the infection rate reported in ticks from Guadeloupe seemed lower compared to in Martinique. The same trend had been reported during previous seroprevalence studies \[[@B7-pathogens-09-00176],[@B8-pathogens-09-00176],[@B10-pathogens-09-00176]\]. Anaplasmosis can be transmitted by vectors other than ticks, and some cattle breeds are known to be more susceptible than others to *Anaplasma* infection \[[@B10-pathogens-09-00176]\]. The difference in *Anaplasma* infection rate in ticks between the two islands may have been due to differences in the cattle populations. Indeed, there are mainly local Creole and mixed European-Creole breeds in Guadeloupe. These are known to be more resistant to anaplasmosis than Brahman and European breeds, which are the main breeds reared in Martinique \[[@B10-pathogens-09-00176]\]. In addition, other factors, including differences in the population dynamics of alternate vectors such as flies, may also have contributed to this difference.

Among the other known TBPs detected, we also found pathogens with low health impact in the Caribbean, almost considered as endosymbionts, such as *R. africae*, *T. velifera* and *T. mutans* in their *A. variegatum* vector and surprisingly in *R. microplus* ticks.

With almost all of the *A. variegatum* found to be infected, the *R. africae* infection rate was the highest ever reported in the Caribbean \[[@B9-pathogens-09-00176],[@B13-pathogens-09-00176],[@B14-pathogens-09-00176],[@B30-pathogens-09-00176]\]. As *A. variegatum* is both the vector and the reservoir of the pathogen, with transovarial and trans-stadial transmission rates reaching 100%, this high level of *R. africae* infection is not surprising per se \[[@B14-pathogens-09-00176],[@B31-pathogens-09-00176]\]. Interestingly, the high *R. africae* infection rate in vector ticks, associated with a very low number of African tick-bite fever cases in the Caribbean, highlights the difficulty, in some cases, of clearly distinguishing between endosymbiosis and pathogenicity \[[@B9-pathogens-09-00176],[@B15-pathogens-09-00176]\]. The biological relationship between *R. africae* and *A. variegatum* as well as the strain variety and virulence of *R. africae* in the Caribbean should be investigated in order to better assess risks and guide prevention measures, especially for travelers \[[@B23-pathogens-09-00176],[@B24-pathogens-09-00176],[@B32-pathogens-09-00176]\]. The absence of direct identification of *R. africae* in *R. microplus* ticks was probably due to lower sensitivity of the specific target design compared to the genus target design. Indeed, *Rickettsia* spp.-positive *R. microplus* samples displayed rather high Ct values, suggesting a low infection level that may have been below the detection limit for *R. africae*. The unusual presence of *R. africae* in *R. microplus* ticks may have been due to the co-occurrence of the two tick species, *R. microplus* and *A. variegatum*, on cattle. As the ticks here were collected partially engorged, the presence of *R. africae* in *R. microplus* may have been due to bacteria circulating in cattle blood picked up by engorging ticks, or to cross-contamination with *R. microplus* ticks co-feeding next to infected *A. variegatum* \[[@B33-pathogens-09-00176],[@B34-pathogens-09-00176]\].

This study provides the first update on the detection of *T. mutans* and *T. velifera* in Caribbean ticks. Indeed, references to these parasites in the Caribbean are relatively old, and no prevalence studies have been conducted since, whether in ticks or in cattle \[[@B5-pathogens-09-00176],[@B6-pathogens-09-00176],[@B35-pathogens-09-00176]\]. The low pathogenicity of these piroplasms may explain the lack of diagnoses and the scarcity of information available on their distribution and prevalence in the Caribbean. However, these parasite species may play an important role in theileriosis management and protection, as chronically infected cattle can develop immunity and heterologous protection against other pathogenic *Theileria* species, such as *Theileria parva* \[[@B36-pathogens-09-00176]\]. Unfortunately, these detections still require further investigations as we did not succeed in confirming these results by conventional or nested PCR, suggesting either a level of infection below the detection threshold, or simply false signals.

Lastly, the high-throughput microfluidic real-time PCR system enabled the detection of unexpected and/or potentially new microorganisms, leading to the recovery of nucleotide sequences of *Anaplasma* spp., *Ehrlichia* spp., *Borrelia* spp. and *Leishmania* spp. in ticks collected in Guadeloupe and Martinique.

The *Ehrlichia* sp. Tick428 sequence detected here formed a cluster with other uncharacterized Ehrlichia species detected in ticks from Asia and Africa \[[@B13-pathogens-09-00176],[@B37-pathogens-09-00176],[@B38-pathogens-09-00176],[@B39-pathogens-09-00176],[@B40-pathogens-09-00176],[@B41-pathogens-09-00176]\]. However, given the highly conserved nature of the 16S rRNA genes, we could not more accurately define phylogenetic relationships within the *Ehrlichia* species group. The *Anaplasma* sp. Tick314 sequence was identified as *Candidatus* Anaplasma boleense, a bacterium described in ticks and mosquitoes in China \[[@B40-pathogens-09-00176],[@B42-pathogens-09-00176]\]. No further information is available regarding the epidemiology of *Candidatus* Anaplasma boleense. These observations highlight the need to set up characterization studies. Indeed, high-throughput detection technologies can highlight the presence of DNA from potentially new microorganisms, but it will still be necessary to isolate and characterize them in order to first confirm their existence and then determine whether their presence in ticks poses a risk to public or animal health.

Here we provided the first report of *Borrelia* spp. in ticks from Guadeloupe and Martinique. Two different sequences were recovered, according to the tick species analyzed. In *A. variegatum*, a sequence named *Borrelia* sp. Tick7 was detected and was closely related to *B. anserina*, the agent of avian spirochetosis. Both of them seemed to define an intermediate position between the relapsing fever and Lyme disease groups. In contrast, the *Borrelia* sp. Tick457 sequence found in the *R. microplus* sample, clustered with uncharacterized *Borrelia* spp. described *R. microplus* specimens from Madagascar and Brazil, such as *Borrelia* sp. strain Mo063b and *Borrelia* sp. BR, and with relapsing fever Borrelia species encountered in hard ticks, including *Borrelia lonestari* and *B. theileri* \[[@B43-pathogens-09-00176],[@B44-pathogens-09-00176]\]. Interestingly, the same observations had recently been made regarding *Borrelia* spp. found in *A. variegatum* and *R. microplus* ticks from Ethiopia and Côte d'Ivoire \[[@B45-pathogens-09-00176],[@B46-pathogens-09-00176]\]. As *A. variegatum* and *R. microplus* were imported into the Caribbean from Africa during the time of the Atlantic triangular trade, we may have detected bacteria probably characterized by an old introduction through infected ticks and subsequent local evolution within their vector over a long period \[[@B4-pathogens-09-00176],[@B47-pathogens-09-00176]\]. *Borrelia* spp. and borreliosis case reports in the Caribbean are scarce and still being debated. In Cuba, one study suggested the presence of antibodies to *Borrelia burgdorferi* sensu stricto in human sera associated with clinical cases of Lyme disease-like syndrome \[[@B48-pathogens-09-00176],[@B49-pathogens-09-00176]\]. However, the real specificity of these serum antibodies has been questioned \[[@B50-pathogens-09-00176]\]. In the US Virgin Islands, seropositivity for *Borrelia hermsii* and closely related species was reported in association with a human case of relapsing fever \[[@B51-pathogens-09-00176]\]. Lastly, erythema migrans-like skin lesions and illness were reported in four Caribbean nationals \[[@B52-pathogens-09-00176]\]. Regarding the importance of *Borrelia* spp. for human and animal health, the characterization of these potential new *Borrelia* species that seemed associated with tropical tick species requires further investigation.

Lastly, *Leishmania* spp. were detected in *R. microplus* specimens from Martinique, and one sequence was identified as *Leishmania martiniquensis* Tick389 (accession number MK049850). Studies on *Leishmania* nomenclature have highlighted the fact that isolates of "*L. siamensis*" have never been officially characterized and that, therefore, this name should not be used \[[@B53-pathogens-09-00176],[@B54-pathogens-09-00176],[@B55-pathogens-09-00176],[@B56-pathogens-09-00176]\]. Thus, since all the sequences, except one, reported as "*L. siamensis*" in databases should be considered as synonyms of *L. martiniquensis*, we assumed the occurrence of *L. martiniquensis* here. Parasites of the genus *Leishmania* are usually transmitted by female phlebotomine sand flies (Diptera: Psychodidae: Phlebotominae) and generally involve a wide variety of animal species, mainly including dogs and canids in the epidemiological cycle. They are responsible for leishmaniasis, a zoonosis widespread in tropical and subtropical areas \[[@B56-pathogens-09-00176]\]. *L. martiniquensis* belongs to the *L. enriettii* complex and has been described in Martinique and Thailand, where it was responsible for both cutaneous and visceral leishmaniosis \[[@B53-pathogens-09-00176],[@B55-pathogens-09-00176],[@B56-pathogens-09-00176],[@B57-pathogens-09-00176],[@B58-pathogens-09-00176]\]. *L. martiniquensis* is suspected to be endemic in Martinique \[[@B57-pathogens-09-00176]\]. Although phlebotomines and rodents are present in Martinique, neither vectors nor reservoirs of this parasite have yet been described \[[@B57-pathogens-09-00176]\]. Our study represents the first report of *L. martiniquensis* in *R. microplus* ticks from the French West Indies. Although *Leishmania* spp. have been reported in ticks (*L. infantum* in *R. sanguineus* s.l., and *L. guyanensis* in *R. microplus* ticks in Peru, for example), the role of ticks in *Leishmania* transmission is still being debated, and no evidence of vector capacity has been reported yet \[[@B59-pathogens-09-00176],[@B60-pathogens-09-00176],[@B61-pathogens-09-00176]\]. Moreover, the finding of *Leishmania* spp. in a tick species that feeds mainly on cattle also raises questions about the potential role of cattle in the epidemiology of leishmaniasis \[[@B62-pathogens-09-00176],[@B63-pathogens-09-00176]\]. The participation of ticks in *Leishmania* epidemiology warrants further investigation, especially since *R. microplus* ticks could parasitize humans \[[@B64-pathogens-09-00176]\].

Surprisingly, co-infections with two or more TBPs were found in more than 50% of the infected ticks, both for *A. variegatum* and *R. microplus* and on the two islands. In addition, we could not identify any exclusion of infection between pathogens. These observations illustrate the efficiency of ticks as reservoirs of multiple pathogens with no apparent significant effects on their life traits.

To conclude, although screening tools are useful for the discovery of pathogens in ticks, the epidemiological significance of such results warrants further analysis. Detecting a microorganism's DNA in ticks, especially in partially engorged ticks removed from the host, does not necessarily mean that the ticks are the biological vector of this microorganism; however, it provides useful information to supplement vector competence studies \[[@B16-pathogens-09-00176]\]. Nevertheless, the detection of potentially new microorganisms in ticks from the French West Indies has opened up new research perspectives for the future on the epidemiology of TBPs in the Caribbean. A region-wide epidemiological survey on TBPs in ticks collected in different countries and territories of the Caribbean area, organized in collaboration with the Caribbean Animal Health Network (CaribVET) in order to strengthen our results, may be an interesting way to supplement and strengthen some of this paper's findings.

4. Materials and Methods {#sec4-pathogens-09-00176}
========================

4.1. Ticks Collected in Guadeloupe and Martinique {#sec4dot1-pathogens-09-00176}
-------------------------------------------------

The ticks used in this study were collected as part of two separate epidemiological surveys conducted in Guadeloupe (between February 2014 and January 2015) and Martinique (between February and March 2015), respectively. In Guadeloupe, adult ticks (any species, any sex) were collected from 40 cattle originating from 22 different herds that were sampled in nine localities situated in six different biotopes (urban area, dry coastal regions, valleys and hills, evergreen seasonal forest, sub-mountainous rainforest and swamp forest). In Martinique, engorged females of *R. microplus* only were collected from cattle in 29 farms participating in a study on acaricide resistance in ticks. All the ticks were collected from cattle with the permission of farmers and cattle owners. The ticks were morphologically identified at species level \[[@B65-pathogens-09-00176]\]. A total of 578 adult ticks were included in the study: 132 *A. variegatum* and 165 *R. microplus* ticks from Guadeloupe and 281 *R. microplus* ticks from Martinique (see maps, [Figure 2](#pathogens-09-00176-f002){ref-type="fig"}). The GPS coordinates of the tick collection sites are available in [Table S2](#app1-pathogens-09-00176){ref-type="app"}. All the ticks were partially engorged and then stored at −80 °C.

4.2. DNA Extraction of Ticks Collected in Guadeloupe and Martinique {#sec4dot2-pathogens-09-00176}
-------------------------------------------------------------------

For 20 mg of tick, 1 mL of recently prepared PBS 1X was added to the sample. The ticks were then washed by gently shaking for 2--3 min at 7 Hz/s in a TissueLyser (Qiagen, Hilden, Germany). After discarding the supernatant, the ticks were frozen at −80 °C for 15--20 min. A steel ball was then added, and the samples were crushed twice for 2 min at 30 Hz/s with the TissueLyser (Qiagen, Hilden, Germany). A total of 450 µL of fresh PBS 1X was added to the samples. The samples were vortexed for 10 s and then centrifuged for 2--3 min at 8000× *g*. Lastly, 20 µL of Proteinase K was added to 150 µL of crushed tick sample, and DNA was extracted using the NucleoSpin® 96 Virus Core Kit (Macherey-Nagel, Düren, Germany) and the Biomek4000 automated platform (Beckman Coulter, Villepinte, France). This protocol enables the simultaneous extraction of both DNA and RNA. Total nucleic acid per sample was eluted in 160 µL of rehydration solution and stored at −80 °C until further use. All the *A. variegatum* ticks were individually extracted, and both individual and pooled extraction have been performed on *R. microplus* ticks. Indeed, as some *R. microplus* specimens were too small to be treated individually (20 mg of tick required), pools of two to four ticks have been carried out when required.

4.3. Assay Design {#sec4dot3-pathogens-09-00176}
-----------------

The list of pathogens to be monitored, the sets of primers and probes required for their detection, as well as the targeted genes are shown in [Table 1](#pathogens-09-00176-t001){ref-type="table"}. Some of the oligonucleotides were specifically designed for the purposes of this study; the others came from Michelet et al., 2014 \[[@B18-pathogens-09-00176]\]. The newly developed oligonucleotides were validated for a range of dilutions of positive controls, including cultures, plasmids and DNA samples ([Table 1](#pathogens-09-00176-t001){ref-type="table"}, [Table S1](#app1-pathogens-09-00176){ref-type="app"}), by real-time TaqMan PCR assays on a LightCycler® 480 (LC480) (Roche Applied Science, Germany). More information on positive control origins are available in [Table S1](#app1-pathogens-09-00176){ref-type="app"}. Real-time PCR assays were performed with LightCycler® 480 Probe Master Mix 1× (Roche Applied Science, Penzberg, Germany), using 200 nM of primers and probes in a final volume of 12 µL, and 2 µL of control DNA was added. The thermal cycling program was as follows: 95 °C for 5 min, 45 cycles at 95 °C for 10 s and 60 °C for 15 s, and one final cooling cycle at 40 °C for 10 s.

4.4. Pre-Amplification of DNA Samples {#sec4dot4-pathogens-09-00176}
-------------------------------------

All the DNA samples were subject to pre-amplification in order to enrich the pathogenic DNA content compared with tick DNA. PerfeCTa® PreAmp SuperMix (Quanta Biosciences, Beverly, MA, USA) was used for DNA pre-amplification following the manufacturer's instructions. All the primers were pooled (except those targeting the tick species), with a final and equal concentration of 45 nM each. The pre-amplification reaction was performed in a final volume of 5 µL containing 1 µL of PerfeCTa PreAmp SuperMix (5X), 1.25 µL of pooled primer mix, 1.25 µL of DNA and 1.5 µL of Milli-Q water, with one cycle at 95 °C for 2 min and 14 cycles at 95 °C for 10 s and 60 °C for 3 min. At the end of the cycling program, the reactions were 1:10 diluted. The pre-amplified DNA were stored at −20 °C until use.

4.5. High-Throughput Microfluidic Real-Time PCR {#sec4dot5-pathogens-09-00176}
-----------------------------------------------

High-throughput microfluidic real-time PCR amplifications were performed using the BioMark™ real-time PCR system (Fluidigm, South San Francisco, CA, USA) and 96.96 dynamic arrays (Fluidigm, South San Francisco, CA, USA), enabling up to 9216 individual reactions to be performed in one run \[[@B18-pathogens-09-00176]\]. Real-time PCRs were performed using 6-carboxyfluorescein (6-FAM)- and Black Hole Quencher (BHQ1)-labeled TaqMan probes with TaqMan Gene Expression Master Mix (Applied Biosystems, Foster City, CA, USA) following the manufacturer's instructions. The cycling conditions were as follows: 2 min at 50 °C and 10 min at 95 °C, followed by 40 cycles of two-step amplification for 15 s at 95 °C and 1 min at 60 °C. The BioMark™ real-time PCR system was used for data acquisition and the Fluidigm real-time PCR analysis software for Ct value determination. Three kinds of controls per chip were used for experiment validation: a negative water control to exclude contamination; a DNA extraction control, corresponding to primers and probes targeting a portion of the 16S rRNA gene of ticks; and an internal control, to check the presence of PCR inhibitors made of DNA from Escherichia coli strain EDL933, added to each sample with specific primers and probes targeting the eae gene \[[@B66-pathogens-09-00176]\]. For the relative specificity analysis of the newly designed Biomark system, DNA of 62 positive controls were used as template ([Table S1](#app1-pathogens-09-00176){ref-type="app"}). Then, for the epidemiological survey of TBPs in Caribbean ticks, the 523 DNA samples of *A. variegatum* and *R. microplus* from Guadeloupe and Martinique were used as template.

4.6. Infection Rates for Ticks from the French West Indies {#sec4dot6-pathogens-09-00176}
----------------------------------------------------------

Depending on the tick species and the island of origin, for each detected pathogen, infection rates (the proportion of infected ticks divided by the total number of ticks analyzed) were calculated. The majority of the samples were single specimens of ticks. When ticks were too small to be treated individually, they were grouped into pools of two to four specimens. Thus, of the 523 samples analyzed, 47 consisted of a pool of two to four tick specimens. The final estimation of infection rates also includes the pools and is therefore expressed as the minimum (assuming at least one positive tick in the pools) and maximum (assuming all positive ticks in the pools) proportions of infected ticks out of the total number of ticks analyzed.

4.7. PCRs and Sequencing for the Confirmation of Results {#sec4dot7-pathogens-09-00176}
--------------------------------------------------------

Conventional PCRs/nested PCRs using primers targeting different genes or regions than those of the BioMark™ system were used to confirm the presence of pathogenic DNA in some field samples and positive controls ([Table 3](#pathogens-09-00176-t003){ref-type="table"}). PCR products were then sequenced by Sanger sequencing approach performed by Eurofins MWG Operon (BIOMNIS-EUROFINS GENOMICS, Nantes, France). Sequences obtained were assembled using BioEdit software (Ibis Biosciences, Carlsbad, CA, USA). An online BLAST (Basic Local Alignment Search Tool) search was used to compare the nucleotide sequences found in this study to reference sequences listed in GenBank sequence databases (NCBI).

4.8. Phylogenetic Sequence Analysis {#sec4dot8-pathogens-09-00176}
-----------------------------------

Alignments were performed using ClustalW \[[@B72-pathogens-09-00176]\]. Maximum likelihood trees were generated by 1000 bootstrap repetitions based on the Tamura-Nei model \[[@B73-pathogens-09-00176]\] in MEGA7 \[[@B74-pathogens-09-00176]\]. The initial tree(s) for the heuristic search were obtained automatically by applying neighbor-joining and BioNJ algorithms to a matrix of pairwise distances estimated using the maximum composite likelihood (MCL) approach and then selecting the topology with superior log likelihood value. The tree was drawn to scale, with branch lengths measured in the number of substitutions per site. The codon positions included were 1st+2nd+3rd+Noncoding. All positions containing gaps and missing data were eliminated. Further information is provided in the figure legends.

5. Conclusions {#sec5-pathogens-09-00176}
==============

Our study demonstrated the high ability of microfluidic real-time PCR technology to provide a rapid overview of the diversity of TBPs of veterinary and medical importance present in ticks from the Caribbean. This innovative high-throughput tool is promising and could significantly improve the surveillance and exploration of TBPs, enabling the rapid screening of multiple microorganisms especially in regions where few epidemiological data are available and TBDs are numerous.
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The following are available online at <https://www.mdpi.com/2076-0817/9/3/176/s1>, Table S1: List of the positive control samples used for the relative specificity analysis of the Biomark system developed in this study, Table S2: GPS coordinates of the tick collection sites and number of ticks collected. A total of 578 adult ticks collected from cattle from Guadeloupe and Martinique were used for the screening of tick-borne pathogens with the newly implemented BioMark™ real-time PCR system, Figure S1: Improvement of detection signals by pre-amplification. Test of primer/probe set sensitivity for a range of dilutions of positive controls by TaqMan real-time PCR using LightCycler 480, before and after pre-amplification. Results of the sensitivity test of the *Leishmania infantum* design using a *Leishmania infantum* culture, before (a) and after (c) pre-amplification; Results of the sensitivity test of the *Rickettsia* spp. design using *Rickettsia conorii*-positive controls (extracted from an infected *Rhipicephalus sanguineus* sensu lato tick), before (b) and after (d) pre-amplification.
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Analysis of the relative specificity of the 61 sets of primers and probe constituting the Biomark system developed in this study.

In order to identify potential cross-reactions, we analyzed the relative specificity of the 61 sets of primers and probe constituting the BioMark system used in this study using 62 positive control samples including DNA from bacterial or parasitic cultures, or DNA from tick or blood samples known to be infected, or plasmidic constructions (see [Table S1](#app1-pathogens-09-00176){ref-type="app"}).

Of the 61 designs, 42 designs were specific of their target. The Tick spp. design, used as a tick nucleic acid extraction control, was able to detect *A. variegatum* and *R. sanguineus* s.l. samples as well as the DNA of the *R. sanguineus* s.l. tick present in the *Rickettsia conorii* positive control as expected ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}). However, the DNA of ticks from the *R. microplus* control sample and other positive controls including tick DNA (such as the *Borrelia lonestari*, *Anaplasma phagocytophilum* controls, etc.) were not detected ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}). The detection ability of this design was corrected by adding the Tick spp. primers during the pre-amplification step; these had initially been excluded since the objective was to enrich pathogenic DNA content compared to tick DNA (data not shown). Eight designs displayed cross-reactions with one to two closely related species, and seven designs displayed unexpected signals corresponding likely to the detection of unexpected co-infection in complex control samples such as DNA extracted from ticks or blood samples ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}). Finally, three designs were removed from the system: one design due to a lack of efficiency (no detection of the target), and two designs were not specific, displaying multiple cross-reactions ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}).

pathogens-09-00176-t0A1_Table A1

###### 

List of designs and their specificity using the BioMark system. CR: cross-reactions with closely related species samples; CI: potential co-infections in control samples.

  Design                                          Target Detection   Specificity   Outgroup Control Samples
  ----------------------------------------------- ------------------ ------------- --------------------------------------------------------------
  *Rickettsia* spp. *gltA*                        *YES*              CI            *Borrelia lonestari* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Ehrlichia chaffensis* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Ehrlichia ewingii* (Infected *A. americanum* ticks)
                                                  *YES*              CI            Panola Mountain *Ehrlichia* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Amblyomma variegatum* (Wild tick)
  *Rickettsia massiliae 23S-5S ITS*               *YES*              *CR*          *Rickettsia slovaca* (Culture)
  *Rickettsia rickettsii 23S-5S ITS*              *YES*              *CR ^1^*      *Rickettsia slovaca* (Culture)
                                                  *YES*                            *Rickettsia conorii* (Infected *R. sanguineus* s.l. ticks)
                                                  *YES*                            *Rickettsia africae* (Culture)
                                                  *YES*                            *Amblyomma variegatum* (Wild tick)
  *Rickettsia conorii sca1*                       *YES*              *CR*          *Rickettsia slovaca* (Culture)
  *Rickettsia africae sca1*                       *YES*              CI            *Amblyomma variegatum* (Wild tick)
  *Rickettsia felis orfB*                         *YES*              CI            *Borrelia lonestari* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Ehrlichia chaffensis* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Ehrlichia ewingii* (Infected *A. americanum* ticks)
                                                  *YES*              CI            Panola Mountain *Ehrlichia* (Infected *A. americanum* ticks)
  *Rickettsia typhi ompB*                         *YES*              *YES*         
  *Rickettsia prowazekii gltA*                    *YES*              *YES*         
  *Borrelia* spp. *23S rRNA*                      *YES*              *YES*         
  *Borrelia burgdorferi* sensu stricto *glpA*     *NO ^1^*                         
  *Borrelia anserina fla*                         *YES*              *YES*         
  *Borrelia lonestari glpQ*                       *YES*              *YES*         
  *Borrelia parkeri gyrB*                         *YES*              *YES*         
  *Borrelia bissettii rpoB*                       *YES*              *YES*         
  *Borrelia theileri glpQ*                        *YES*              *YES*         
  *Bartonella* spp. *ssrA*                        *YES*              *YES*         
  *Bartonella bacilliformis rpoB*                 *YES*              *CR*          *Bartonella henselae* (Culture)
  *Bartonella henselae ribC*                      *YES*              *CR*          *Bartonella bacilliformis* (Culture)
  *Bartonella vinsonii* subsp. *berkhoffii ITS*   *YES*              *YES*         
  *Coxiella burnetii icd*                         *YES*              *YES*         
  *Coxiella burnetii IS 1111*                     *YES*              *YES*         
  *Francisella tularensis tul4*                   *YES*              *YES*         
  *Francisella tularensis fopA*                   *YES*              *YES*         
  *Anaplasma* spp. *16S rRNA*                     *YES*              *YES*         
  *Anaplasma marginale msp1b*                     *YES*              *YES*         
  *Anaplasma phagocytophilum msp2*                *YES*              *YES*         
  *Anaplasma platys groEL*                        *YES*              *YES*         
  *Anaplasma bovis groEL*                         *YES*              *YES*         
  *Anaplasma ovis msp4*                           *YES*              *YES*         
  *Ehrlichia* spp. *16S rRNA*                     *YES*              *YES*         
  *Ehrlichia canis gltA*                          *YES*              *YES*         
  *Ehrlichia chaffeensis dsb*                     *YES*              *YES*         
  *Ehrlichia ewingii dsb*                         *YES*              *YES*         
  *Ehrlichia ruminantium gltA*                    *YES*              *YES*         
  Panola Mountain *Ehrlichia gltA*                *YES*              *YES*         
  *Neoehrlichia mikurensis groEL*                 *YES*              *YES*         
  *Aegyptianella pullorum groEL*                  *YES*              *YES*         
  *Apicomplexa 18S rRNA*                          *YES*              CI            *Borrelia lonestari* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Anaplasma marginale* (Infected cow blood)
                                                  *YES*              CI            Panola Mountain *Ehrlichia* (Infected *A. americanum* ticks)
                                                  *YES*              CI            *Neoehrlichia mikurensis* (Infected rodent blood)
                                                  *YES*              CI            *Rhipicephalus sanguineus* s.l. (Wild tick)
  *Babesia canis vogeli hsp70*                    *YES*              *CR*          *Babesia canis canis* (Infected dog blood)
  *Babesia ovis 18S rRNA*                         *YES*              *CR ^1^*      *Rickettsia massiliae* (Culture)
                                                  *YES*                            *Borrelia lonestari* (Infected *A. americanum* ticks)
                                                  *YES*                            *Anaplasma marginale* (Infected cow blood)
                                                  *YES*                            *Ehrlichia chaffensis* (Infected *A. americanum* ticks)
                                                  *YES*                            *Ehrlichia ewingii* (Infected *A. americanum* ticks)
                                                  *YES*                            Panola Mountain *Ehrlichia* (Infected *A. americanum* ticks)
                                                  *YES*                            *Neoehrlichia mikurensis* (Infected rodent blood)
                                                  *YES*                            *Babesia divergens* (Culture)
                                                  *YES*                            *Babesia canis rossi* (Infected dog blood)
                                                  *YES*                            *Babesia canis canis* (Infected dog blood)
                                                  *YES*                            *Babesia canis vogeli* (Infected dog blood)
                                                  *YES*                            *Babesia microti* (Culture)
                                                  *YES*                            *Theileria annulata* (Culture)
                                                  *YES*                            *Theileria lestoquardi* (Culture)
                                                  *YES*                            *Theileria parva* (Culture)
                                                  *YES*                            *Hepatozoon canis* (Infected dog blood)
                                                  *YES*                            *Rhipicephalus sanguineus* s.l. (Wild tick)
  *Babesia bigemina 18S rRNA*                     *YES*              CI            *Anaplasma marginale* (Infected cow blood)
  *Babesia gibsoni Rap1*                          *YES*              *YES*         
  *Babesia caballi Rap1*                          *YES*              *YES*         
  *Babesia bovis CCTeta*                          *YES*              *YES*         
  *Babesia duncani ITS2*                          *YES*              *YES*         
  *Babesia microti CCTeta*                        *YES*              *CR*          *Babesia canis canis* (Infected dog blood)
  *Theileria parva 18S rRNA*                      *YES*              *CR*          *Theileria annulata* (Culture)
                                                  *YES*              *CR*          *Theileria lestoquardi* (Culture)
  *Theileria mutans ITS*                          *YES*              *YES*         
  *Theileria velifera 18S rRNA*                   *YES*              *YES*         
  *Theileria equi ema1*                           *YES*              *YES*         
  *Cytauxzoon felis ITS2*                         *YES*              *YES*         
  *Hepatozoon spp 18S rRNA*                       *YES*              CI            *Neoehrlichia mikurensis* (Infected rodent blood)
                                                  *YES*              CI            *Rhipicephalus sanguineus* s.l. (Wild tick)
  *Hepatozoon canis 18S rRNA*                     *YES*              CI            *Rhipicephalus sanguineus* s.l. (Wild tick)
  *Hepatozoon americanum 18S rRNA*                *YES*              CR            *Hepatozoon canis* (Infected dog blood)
                                                  *YES*              CI            *Rhipicephalus sanguineus* s.l. (Wild tick)
  *Leishmania spp hsp70*                          *YES*              *YES*         
  *Leishmania infantum ITS*                       *YES*              *YES*         
  *Rangelia vitalii 18S rRNA*                     *YES*              *YES*         
  *Tick spp*. *16S rRNA*                          *YES*              *YES ^2^*     
  *Amblyomma variegatum ITS2*                     *YES*              *YES*         
  *Rhipicephalus microplus ITS2*                  *YES*              *YES*         
  *Rhipicephalus sanguineus* s.l. *ITS2*          *YES*              *YES*         

^1^ Designs removed from the screening analysis. ^2^ Tick spp. primers required to be part of the pre-amplification mix in order to achieve correct detection signals.

Regarding the seven designs displaying unexpected signals, we decided to explore the hypothesis of potential co-infection in controls corresponding to DNA from ticks or blood samples using conventional PCR and amplicon sequencing ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}).

Both the *Rickettsia* spp. and *Rickettsia felis* designs gave positive results when testing the *Borrelia lonestari*, Panola Mountain *Ehrlichia*, *Ehrlichia ewingii* and *Ehrlichia chaffensis* controls. All these samples corresponded to DNA extracted from infected *Amblyomma americanum* collected in the field (USA). This result supports the fact that a *Rickettsia* species may have been present in these samples, whether it was *Rickettsia felis* or a closely related *Rickettsia* spp. infecting *Amblyomma americanum* ticks. When testing the Panola Mountain *Ehrlichia* sample for *Rickettsia* spp. by conventional PCR targeting the gltA gene \[[@B67-pathogens-09-00176]\], we obtained a 382 bp sequence (accession number MK049843) sharing 99% sequence identity with *Rickettsia* spp. (MF511253.1) ([Table A2](#pathogens-09-00176-t0A2){ref-type="table"}). This result, in addition to natural co-infections documented in *Amblyomma americanum* ticks, suggest that the detection of *Rickettsia* spp., within the four outgroup positive controls corresponding to *Amblyomma americanum* DNA, in this assay did not correspond to cross-reactions \[[@B75-pathogens-09-00176],[@B76-pathogens-09-00176]\]. Moreover, the *Amblyomma variegatum* sample, corresponding to ticks collected from the field, was found to be positive for both *Rickettsia* spp. and *Rickettsia africae*. As this sample originated from Guadeloupe, where *Rickettsia africae* circulates, this result may have been in agreement with a natural infection \[[@B9-pathogens-09-00176]\].

pathogens-09-00176-t0A2_Table A2

###### 

Taxonomic assignment of the sequences obtained after sequencing PCR products to confirm the presence of co-infections in complex control samples corresponding to DNA extracted from wild ticks or blood samples. AN: accession number, % I: percentage identity, % C: percentage coverage.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Tested Control Sample              Tested for          AN         Length (bp)   Closest Homology                                             \% I   \% C   AN
  ---------------------------------- ------------------- ---------- ------------- ------------------------------------------------------------ ------ ------ ------------
  Panola Mountain *Ehrlichia*\       *Rickettsia* spp.   MK049843   382           *Rickettsia* spp.                                            99     100    MF511253.1
  (Infected *A. americanum* ticks)                                                                                                                           

  *Neoehrlichia mikurensis*\         *Hepatozoon* spp.   MK071735   169           *Hepatozoon* spp.                                            99     100    AB771515.1
  (Infected rodent blood)                                                                                                                                    

  *Anaplasma marginale*              Apicomplexa         MK071737   104           *Babesia* spp.*, Theileria* spp. (including *B. bigemina*)   100    99     MG604302.1

  (Infected cow blood)                                                                                                                                       

  Panola Mountain *Ehrlichia*\       Apicomplexa         MK071736   102           *Theileria* spp*.*\                                          98     100    MH085203.1
  (Infected *A. americanum* ticks)                                                (including *T. cervi*)                                                     

  *Borrelia lonestari*               Apicomplexa                                                                                                             

  (Infected *A. americanum* ticks)                                                                                                                           
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Moreover, the *Rhipicephalus sanguineus* s.l. sample was positive with four designs targeting parasites: Apicomplexa, *Hepatozoon* spp., *Hepatozoon canis* and *Hepatozoon americanum*. Since *Rhipicephalus sanguineus* s.l. ticks are involved in the epidemiology of tick-borne parasites including *Hepatozoon* spp., these results strongly suggest the occurrence of such parasites in the biological sample \[[@B77-pathogens-09-00176]\]. Thus, these observations suggest that our designs were actually capable of detecting pathogens present in naturally infected ticks rather than giving an unsuspected cross-reaction. The *Neoehrlichia mikurensis* sample, corresponding to DNA extracted from rodent blood, was also found to be positive for both Apicomplexa and *Hepatozoon* spp. The amplicon obtained from this sample with the *Hepatozoon* spp. design was sequenced. The obtained 169 bp sequence (accession number MK071735) displayed 99% sequence identity with the *Hepatozoon* spp. sequences (AB771515.1) ([Table A2](#pathogens-09-00176-t0A2){ref-type="table"}). As rodents can be infected with *Hepatozoon* parasites, this result could also reflect a natural infection \[[@B78-pathogens-09-00176]\]. The *Anaplasma marginale* sample, corresponding to a blood sample from an experimentally infected cow, was also found to be positive for both Apicomplexa and *Babesia bigemina*. The amplicon obtained from this sample with the Apicomplexa design was sequenced. The obtained 104 bp sequence (accession number MK071737) displayed 99% sequence identity with the Apicomplexan sequences, including *Babesia bigemina* (MG604302.1) ([Table A2](#pathogens-09-00176-t0A2){ref-type="table"}). As *Babesia bigemina* and *Anaplasma marginale* are two cattle pathogens that have often evolved in the same region and are transmitted by the same vector tick, co-infections with these two pathogens have already been reported \[[@B79-pathogens-09-00176]\]. Thus, this cross-reaction may again have been a reflection of parasite co-infections. Lastly, Apicomplexa also gave positive results in the *Borrelia lonestari* and Panola Mountain *Ehrlichia* controls. As highlighted previously, these two controls corresponded to DNA extracted from *A. americanum* ticks. The amplicons obtained from these two samples with the Apicomplexa design were sequenced. The two obtained 102 bp sequences (accession number MK071736) were identical and displayed 98% sequence identity with the *Theileria cervi* sequences (MH085203.1) ([Table A2](#pathogens-09-00176-t0A2){ref-type="table"}). As *Theileria cervi* is a common deer pathogen found in *Amblyomma americanum*, the occurrence of this parasite in these two control samples could explain the unexpected signals \[[@B80-pathogens-09-00176],[@B81-pathogens-09-00176]\].

Analysis of the co-infections detected in *Amblyomma variegatum* and *Rhipicephalus microplus* ticks collected in Guadeloupe and Martinique.

Here we reported the co-infections observed in *Amblyomma variegatum* (n = 132 samples), *Rhipicephalus microplus* collected in Guadeloupe (n = 116 samples, including individual and pooled specimens) and Martinique (n = 275 samples, including individual and pooled specimens) ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). We combined the results obtained with the *Rickettsia* spp. and the *R. africae* design, assuming that only *R. africae* have been detected in the Caribbean samples analyzed here. In addition, *Anaplasma* spp. results here correspond to samples only positive for *Anaplasma* spp. and not for *A. marginale*, as well, *Ehrlichia* spp. results here correspond to samples only positive for *Ehrlichia* spp. and not for *E. ruminantium*.

pathogens-09-00176-t0A3_Table A3

###### 

Co-infection analysis in *A. variegatum* (n = 132 samples) and *R. microplus* collected in Guadeloupe (n = 116 samples) and Martinique (n = 275 samples).

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                 *A. variegatum* Sample (Percentage)   *R. microplus* Sample from Guadeloupe (Percentage)   *R. microplus* Sample from Martinique (Percentage)
  ------------------------------ --------------------------------------------------------------- ------------------------------------- ---------------------------------------------------- ----------------------------------------------------
  Total of sample                132                                                             116                                   275                                                  

  Total of non-infected sample   1 (0.8)                                                         51 (44)                               52 (19)                                              

  Total of\                      131 (99.2)                                                      65 (56)                               223 (81)                                             
  infected sample                                                                                                                                                                           

  Single infections              Total                                                           69 (52.3)                             47 (40.5)                                            99 (36)

                                 *R. africae ^1^*                                                68 (51.5)                             15 (12.9)                                            0

                                 *Anaplasma* spp. ^2^                                                                                  1 (0.9)                                              10 (3.6)

                                 *A. marginale*                                                  0                                     2 (1.7)                                              22 (8)

                                 *Ehrlichia* spp. ^3^                                            0                                     3 (2.6)                                              43 (15.6)

                                 *Borrelia* spp.                                                 0                                     0                                                    3 (1.1)

                                 *B. bigemina*                                                   0                                     1 (0.9)                                              7 (2.5)

                                 *T. velifera*                                                   1 (0.8)                               25 (21.6)                                            14 (5.1)

  Co-infections (2)              *Total*                                                         53 (40.2)                             16 (13.8)                                            88 (32)

                                 *R. africae ^1^*/*T. velifera*                                  47 (35.6)                             6 (5.2)                                              0

                                 *R. africae ^1^/Borrelia* spp.                                  3 (2.3)                               0                                                    0

                                 *R. africae ^1^/E. ruminantium*                                 3 (2.3)                               0                                                    0

                                 *Anaplasma* spp. ^2^/*Borrelia* spp.                            0                                     1 (0.9)                                              0

                                 *Anaplasma* spp. ^2^/*T. velifera*                              0                                     2 (1.7)                                              3 (1.1)

                                 *Anaplasma* spp. ^2^/*Ehrlichia* spp. ^3^                       0                                     0                                                    6 (2.2)

                                 *A. marginale*/*T. velifera*                                    0                                     2 (1.7)                                              10 (3.6)

                                 *A. marginale*/*Borrelia* spp.                                  0                                     0                                                    3 (1.1)

                                 *A. marginale*/*Ehrlichia* spp. ^3^                             0                                     0                                                    39 (14.29)

                                 *A. marginale*/*B. bigemina*                                    0                                     0                                                    4 (1.5)

                                 *Ehrlichia* spp. ^3^/*R. africae ^1^*                           0                                     2 (1.7)                                              0

                                 *Ehrlichia* spp. ^3^/*T. velifera*                              0                                     1 (0.9)                                              8 (2.9)

                                 *Ehrlichia* spp. ^3^/*Borrelia* spp.                            0                                     0                                                    3 (1.1)

                                 *Ehrlichia* spp. ^3^/*Leishmania* spp.                          0                                     0                                                    1 (0.4)

                                 *T. velifera*/*B. bigemina*                                     0                                     0                                                    10 (3.6)

                                 *T. velifera*/*T. mutans*                                       0                                     2 (1.7)                                              1 (0.4)

  Co-infections (3)              *Total*                                                         8 (6.1)                               2 (1.7)                                              26 (9.5)

                                 *R.africae ^1^/E. ruminantium/T. velifera*                      3 (2.3)                               0                                                    0

                                 *R. africae ^1^/Borrelia* spp./*T. velifera*                    3 (2.3)                               0                                                    0

                                 *R. africae ^1^/T. velifera*/*T. mutans*                        2 (1.5)                               1 (0.6)                                              0

                                 *R. africae ^1^/A. marginale*/*Ehrlichia* spp. ^3^              0                                     1 (0.6)                                              0

                                 *A. marginale*/*Ehrlichia* spp. ^3^/*B. bigemina*               0                                     0                                                    8 (2.9)

                                 *A. marginale*/*Ehrlichia* spp. ^3^/*B. bovis*                  0                                     0                                                    1 (0.4)

                                 *A. marginale*/*Ehrlichia* spp. ^3^/*T. velifera*               0                                     0                                                    15 (5.5)

                                 *Anaplasma* spp. ^2^/*Ehrlichia* spp. ^3^/*B. bigemina*         0                                     0                                                    1 (0.4)

                                 *Anaplasma* spp. ^2^/*Ehrlichia* spp. ^3^/*T. velifera*         0                                     0                                                    1 (0.4)

  Co-infections (4)              *Total*                                                         1 (0.8)                               0                                                    9 (3.3)

                                 *R. africae ^1^*/*T. velifera*/*Borrelia* spp./\                1 (0.8)                               0                                                    0
                                 *E. ruminantium*                                                                                                                                           

                                 *A. marginale*/*Borrelia* spp./*T. velifera*/\                  0                                     0                                                    1 (0.4)
                                 *T. mutans*                                                                                                                                                

                                 *A. marginale*/*Ehrlichia* spp. ^3^/*T. velifera*/\             0                                     0                                                    5 (1.8)
                                 *B. bigemina*                                                                                                                                              

                                 *A. marginale*/*Ehrlichia* spp. ^3^ /*T. velifera*/*B. bovis*   0                                     0                                                    1 (0.4)

                                 *A. marginale*/*Leishmania* spp./*T. velifera*/\                0                                     0                                                    1 (0.4)
                                 *T. mutans*                                                                                                                                                

                                 *Anaplasma* spp. ^2^/*Ehrlichia* spp. ^3^/*Borrelia* spp./\     0                                     0                                                    1 (0.4)
                                 *T. velifera*                                                                                                                                              

  Co-infections (5)              *Total*                                                         0                                     0                                                    1 (0.4)

                                 *A. marginale*/*Ehrlichia* spp. ^3^/*Borrelia* spp./\           0                                     0                                                    1 (0.4)
                                 *T. velifera*/*T. mutans*                                                                                                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^1^ Assuming that all the *Rickettsia* spp. found in *Rhipicephalus microplus* samples from Guadeloupe were *R. africae*. ^2^ Sample positive for *Anaplasma* spp. and not for *A. marginale*. ^3^ Sample positive for *Ehrlichia* spp. and not for *E. ruminantium*.

Almost all of the *A. variegatum* samples from Guadeloupe were infected with at least one microorganism (99.2) ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). Interestingly, only 56 of the *R. microplus* samples from Guadeloupe were infected with at least one microorganism, whereas this rate reached 81 of the *R. microplus* from Martinique ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). Most of the positive samples corresponded to single infection or co-infection with two microorganisms in both tick species. Then, less than 10 of the tick samples displayed co-infections with three microorganisms ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). Finally, only one *A. variegatum* sample from Guadeloupe and nine *R. microplus* samples from Martinique were co-infected with four microorganisms, and one *R. microplus* from Martinique was found infected with five microorganisms ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}).

The majority of the *A. variegatum* samples displayed single infections with *R. africae* (52) or co-infections with *R. africae* and *T. velifera* (36) ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). Nevertheless, no negative or positive associations have been detected between the microorganisms detected in *A. variegatum* samples ([Table A4](#pathogens-09-00176-t0A4){ref-type="table"}). At least, the presence of *R. africae* do not seem to interfere with the presence of *T. velifera* ([Table A4](#pathogens-09-00176-t0A4){ref-type="table"}).

pathogens-09-00176-t0A4_Table A4

###### 

Co-occurrence matrix of the microorganisms detected in *A. variegatum* samples collected in Guadeloupe (n = 132 samples). No negative or positive association have been detected when performing a co-occurrence test using the co-occur function (α = 0.05) and R version 3.6.0 (2019-04-26).

                         *E. ruminantium*   *Borrelia* spp.   *R. africae*   *T. mutans*   *T. velifera*
  ---------------------- ------------------ ----------------- -------------- ------------- ---------------
  ***E. ruminantium***   7                  **1**             **7**          **0**         **4**
  ***Borrelia* spp.**                       7                 **7**          **0**         **4**
  ***R. africae***                                            130            **2**         **56**
  ***T. mutans***                                                            2             **2**
  ***T. velifera***                                                                        57

Among the 116 *R. microplus* samples from Guadeloupe analyzed here, most of the positive samples presented single-infection (40.5), with *R. africae* (12.9) or *T. velifera* (21.6) ([Table A3](#pathogens-09-00176-t0A3){ref-type="table"}). As *R. microplus* is not considered as a vector of both of these microorganisms, we made the hypothesis of a possible contamination of this tick species via infected bovine blood still present in engorged tick, and/or via co-feeding with infected *A. variegatum* ticks. Interestingly, if we remove *R. africae*, *T. velifera* and *T. mutans* from the screening analysis, the percentage of infected *R. microplus* from Guadeloupe dropped drastically to 13.8% (16/116 samples infected with at least one microorganism). This observation is particularly surprising when comparing this rate to the 81 infected *R. microplus* from Martinique (see below). When testing for co-occurrence linkage, two positive associations have been detected between the microorganisms detected in *R. microplus* samples from Guadeloupe, including *T. velifera*/*T. mutans* and *Anaplasma* spp./*Borrelia* spp. ([Table A5](#pathogens-09-00176-t0A5){ref-type="table"}). Co-infections and positive associations between *T. velifera* and *T. mutans* have already been reported in the literature, such as in cattle sera from Uganda and Kenya \[[@B82-pathogens-09-00176],[@B83-pathogens-09-00176]\]. Regarding the few samples positive for *Anaplasma* spp. and *Borrelia* spp., the result of the co-occurrence test should be taken with caution and deserves further investigation. Nevertheless, no exclusion seemed to occur between the microorganisms detected in *R. microplus* from Guadeloupe ([Table A5](#pathogens-09-00176-t0A5){ref-type="table"}).

pathogens-09-00176-t0A5_Table A5

###### 

Co-occurrence matrix of the microorganisms detected in *R. microplus* samples collected in Guadeloupe (n = 116 samples). \*: Positive association detected when performing a co-occurrence test using the co-occur function (α = 0.05) and R version 3.6.0 (2019-04-26).

                            *A. marginale*   *Borrelia* spp.   *R. africae*   *T. mutans*   *T. velifera*   *B. bigemina*   *Anaplasma* spp.^1^   *Ehrlichia* spp.^2^
  ------------------------- ---------------- ----------------- -------------- ------------- --------------- --------------- --------------------- ---------------------
  ***A. marginale***        5                0                 1              0             2               0               0                     1
  ***Borrelia* spp.**                        1                 0              0             0               0               **1\***               0
  ***R. africae***                                             25             1             7               0               0                     3
  ***T. mutans***                                                             3             **3\***         0               0                     0
  ***T. velifera***                                                                         39              0               2                     1
  ***B. bigemina***                                                                                         1               0                     0
  ***Anaplasma* spp.^1^**                                                                                                   4                     0
  ***Ehrlichia* spp.^2^**                                                                                                                         7

^1^ Sample positive for *Anaplasma* spp. and not for *A. marginale*. ^2^ Sample positive for *Ehrlichia* spp. and not for *E. ruminantium*.

Among the 275 *R. microplus* samples from Guadeloupe, most of the samples presented single-infection (36) and co-infections with two microorganisms (32) ([Table A1](#pathogens-09-00176-t0A1){ref-type="table"}). Five positive associations have been detected between the microorganisms detected in *R. microplus* samples from Martinique ([Table A6](#pathogens-09-00176-t0A6){ref-type="table"}). *T. mutans* have been found in positive association with *T. velifera*, as previously observed in the same tick species from Guadeloupe, and with *Leishmania* spp. and *Borrelia* spp. In addition, *T. velifera* were found in positive association with *B. bigemina* and *Ehrlichia* spp. with *A. marginale.* Finally, no negative associations have been reported between the microorganisms detected in *R. microplus* from Martinique ([Table A6](#pathogens-09-00176-t0A6){ref-type="table"}).

pathogens-09-00176-t0A6_Table A6

###### 

Co-occurrence matrix of the microorganisms detected in *R. microplus* samples collected in Martinique (n = 275 samples). (\*) Positive associations detected when performing a co-occurrence test using the co-occur function (α = 0.05) and R version 3.6.0 (2019-04-26).

                            *A. marginale*   *Borrelia* spp.   *Leishmania* spp.   *T. mutans*   *T. velifera*   *B. bigemina*   *B. bovis*   *Anaplasma* spp.^1^   *Ehrlichia* spp.^2^
  ------------------------- ---------------- ----------------- ------------------- ------------- --------------- --------------- ------------ --------------------- ---------------------
  ***A. marginale***        111              5                 1                   3             34              17              2            0                     **70\***
  ***Borrelia* spp.**                        12                0                   **2\***       3               0               0            1                     5
  ***Leishmania* spp.**                                        2                   **1\***       1               0               0            0                     1
  ***T. mutans***                                                                  4             **4\***         0               0            0                     1
  ***T. velifera***                                                                              72              **15\***        1            5                     32
  ***B. bigemina***                                                                                              35              0            1                     14
  ***B. bovis***                                                                                                                 2            0                     2
  ***Anaplasma* spp.^1^**                                                                                                                     22                    9
  ***Ehrlichia* spp.^2^**                                                                                                                                           134

^1^ Sample positive for *Anaplasma* spp. and not for *A. marginale*. ^2^ Sample positive for *Ehrlichia* spp. and not for *E. ruminantium*.

![BioMark^TM^ dynamic array system specificity test (96.96 chip). Each square corresponds to a single real-time PCR reaction, where rows indicate the pathogen in the sample and columns represent the target of the primer/probe set. Ct values for each reaction are represented by a color gradient; the color scale is shown on the right y-axis. The darkest shades of blue and black squares are considered as negative reactions with Ct \> 30.](pathogens-09-00176-g001){#pathogens-09-00176-f001}

![Infection rates in ticks collected in Guadeloupe and Martinique. Number of positive *A. variegatum* ticks (out of 132) and *R. microplus* ticks from Guadeloupe (out of 165) and Martinique (out of 281). On the maps, black dots indicate the collection sites of non-infected tick samples and colored dots indicate the collection sites of infected tick samples; The dot color determine the bacterial and parasitic genus of the microorganism found as indicated in the table; IR: Infection rate. As some *R. microplus* samples were pooled, we have presented minimum and maximum tick infection rates.](pathogens-09-00176-g002){#pathogens-09-00176-f002}

![Phylogenetic analysis of 16S rRNA sequences of *Ehrlichia* spp. Phylogenetic analysis of 16S rRNA sequences of *Ehrlichia* spp. using the maximum likelihood method based on the Tamura--Nei model. In the phylogenetic tree, GenBank sequences, species designations and strain names are given. The sequences investigated in the present study are marked with a black circle (*Ehrlichia* sp. Tick428, accession number MK049849) and a black diamond (*Ehrlichia ruminantium* Tick116, accession number MK049848). The tree with the highest log likelihood (−413.76) is shown. The percentage of trees in which the associated taxa clustered together is shown above the branches (bootstrap values). The analysis involved 25 nucleotide sequences. There were a total of 206 positions in the final dataset.](pathogens-09-00176-g003){#pathogens-09-00176-f003}

![Phylogenetic analysis of 16S rRNA sequences of *Anaplasma* spp. Phylogenetic analysis of 16S rRNA sequences of *Anaplasma* spp. using the maximum likelihood method based on the Tamura--Nei model. In the phylogenetic tree, GenBank sequences, species designations and strain names are given. The sequences investigated in the present study are marked with a black triangle (*Anaplasma* sp. Tick283, accession number MK049844) and a black square (*Anaplasma* sp. Tick314, accession number MK049845). The tree with the highest log likelihood (−473.44) is shown. The percentage of trees in which the associated taxa clustered together is shown above the branches (bootstrap values). The analysis involved 12 nucleotide sequences. There were a total of 243 positions in the final dataset.](pathogens-09-00176-g004){#pathogens-09-00176-f004}

![Phylogenetic analysis of flaB sequences of *Borrelia* spp. Phylogenetic analysis of flaB sequences of *Borrelia* spp. using the maximum likelihood method based on the Tamura--Nei model. In the phylogenetic tree, GenBank sequences, species designations and strain names are given. The sequences investigated in the present study are marked with a black circle (*Borrelia* sp. Tick457, accession number MK049847) and a black triangle (*Borrelia* sp. Tick7, accession number MK049846). The Lyme disease and relapsing fever clades of *Borrelia* are marked. The tree with the highest log likelihood (−963.24) is shown. The percentage of trees in which the associated taxa clustered together is shown above the branches (bootstrap values). The analysis involved 16 nucleotide sequences. There was a total of 245 positions in the final dataset.](pathogens-09-00176-g005){#pathogens-09-00176-f005}

![Co-infections detected in (a) *Amblyomma variegatum* (n = 132 samples) and (b) *Rhipicephalus microplus* collected in Guadeloupe (n = 116 samples) and (c) *Rhipicephalus microplus* collected in Martinique (n = 275 samples).](pathogens-09-00176-g006){#pathogens-09-00176-f006}

pathogens-09-00176-t001_Table 1

###### 

List of primer/probe sets constituting the BioMark system, with the positive controls used for their validation (new designs mainly). \*: Design from Michelet et al., 2014 \[[@B18-pathogens-09-00176]\]. \*\*: include all the controls belonging to the genus described in the table and targeted by specific design. Plasmids used as control are recombinant PBluescript IISK+ containing the target gene.

  Microorganisms                                                       Target                              Design Name             Sequence (5′ à 3′)           Length (bp)   Controls
  -------------------------------------------------------------------- ----------------------------------- ----------------------- ---------------------------- ------------- ----------------------------------------------------------------------------------------------------------------------------------
  *Rickettsia* spp.                                                    gltA                                Rick_spp_gltA_F         GTCGCAAATGTTCACGGTACTT       78            \*\*, Culture of *R. slovaca*
  Rick_spp_gltA_R                                                      TCTTCGTGCATTTCTTTCCATTG                                                                                
  Rick_spp_gltA_P                                                      TGCAATAGCAAGAACCGTAGGCTGGATG                                                                           
  *Rickettsia massiliae \**                                            ITS                                 Ri_ma_ITS_F             GTTATTGCATCACTAATGTTATACTG   128           Culture
  Ri_ma_ITS_R                                                          GTTAATGTTGTTGCACGACTCAA                                                                                
  Ri_ma_ITS_P                                                          TAGCCCCGCCACGATATCTAGCAAAAA                                                                            
  *Rickettsia rickettsii \**                                           ITS                                 Ri_ri_ITS_F             TCTACTCACAAAGTTATCAGGTTAA    124           Plasmid
  Ri_ri_ITS_R                                                          CCTACGATACTCAGCAAAATAATTT                                                                              
  Ri_ri_ITS_P                                                          TCGCTGGATATCGTTGCAGGACTACAG                                                                            
  *Rickettsia conorii*                                                 sca1                                Ri_co_sca1_F            GTAGATGCTTCATAGAATACTGC      88            Infected *Rhipicephalus sanguineus* s.l.
  Ri_co_sca1_R                                                         CCAAATTTAGTCTACCTTGTGATC                                                                               
  Ri_co_sca1_P                                                         TCCTCCTGACGTATTAAAAGAAGCTGAAGCT                                                                        
  *Rickettsia africae*                                                 sca1                                Ri_af_sca1_F            GATACGACAAGTACCTCGCAG        122           Culture
  Ri_af_sca1_R                                                         GGATTATATACTTTAGGTTCGTTAG                                                                              
  Ri_af_sca1_P                                                         CAGATAGGAACAGTAATTGTAACGGAACCAG                                                                        
  *Rickettsia felis*                                                   orfB                                Ri_fel_orfB_F           ACCCTTTTCGTAACGCTTTGC        163           Culture
  Ri_fel_orfB_R                                                        TATACTTAATGCTGGGCTAAACC                                                                                
  Ri_fel_orfB_P                                                        AGGGAAACCTGGACTCCATATTCAAAAGAG                                                                         
  *Rickettsia typhi*                                                   ompB                                Ri_typ_ompB_F           CAGGTCATGGTATTACTGCTCA       133           Culture
  Ri_typ_ompB_R                                                        GCAGCAGTAAAGTCTATTGATCC                                                                                
  Ri_typ_ompB_P                                                        ACAAGCTGCTACTACAAAAAGTGCTCAAAATG                                                                       
  *Rickettsia prowazekii*                                              gltA                                Ri_pro_gltA_F           CAAGTATCGGTAAAGATGTAATCG     151           Plasmid
  Ri_pro_gltA_R                                                        TATCCTCGATACCATAATATGCC                                                                                
  Ri_pro_gltA_P                                                        ATATAAGTAGGGTATCTGCGGAAGCCGAT                                                                          
  *Borrelia* spp. *\**                                                 23S rRNA                            Bo_bu_sl_23S_F          GAGTCTTAAAAGGGCGATTTAGT      73            \*\*, Culture of *B. afzelii, B. garinii*, *B. valaisiana*, *B. lusitaniae*, *B. recurrentis*
  Bo_bu_sl-23S_R                                                       CTTCAGCCTGGCCATAAATAG                                                                                  
  Bo_bu_sl_23S_P                                                       TAGATGTGGTAGACCCGAAGCCGAGT                                                                             
  *Borrelia burgdorferi* sensu stricto                                 glpA                                Bo_bu_glpA_F            GCAATTACAAGGGGGTATAAAGC      206           Culture
  Bo_bu_glpA_R                                                         GGCGTGATAAGTGCACATTCG                                                                                  
  Bo_bu_glpA_P                                                         TTAATTAAACGGGGTGCATTCTTCTCAAGAATG                                                                      
  *Borrelia anserina*                                                  fla                                 Bor_ans_fla_F           GGAGCACAACAAGAGGGAG          76            Plasmid
  Bor_ans_fla_R                                                        TTGGAGAATTAACCCCACCTG                                                                                  
  Bor_ans_fla_P                                                        TGCAAGCAACTCCAGCTCCAGTAGCT                                                                             
  *Borrelia lonestari*                                                 glpQ                                Bor_lon_glpQ_F          GATCCAGAACTTGATACAACCAC      99            Infected *Amblyomma americanum*
  Bor_lon_glpQ_R                                                       TTCATCTAGTGAGAAGTCAGTAG                                                                                
  Bor_lon_glpQ_P                                                       AGTAATATCGTCCGTCTTCCCTAGCTCG                                                                           
  *Borrelia parkeri*                                                   gyrB                                Bor_par_gyrB_F          GCAAAACGATTCAAAGTGAGTCC      184           Culture
  Bor_par_gyrB_R                                                       CTCATTGCCTTTAAGAAACCACTT                                                                               
  Bor_par_gyrB_P                                                       TTAAAACCAGCAACATGAGTTCCTCCTTCTC                                                                        
  *Borrelia bissettii \**                                              rpoB                                Bo_bi_rpoB_F            GCAACCAGTCAGCTTTCACAG        118           Plasmid
  Bo_bi_rpoB_R                                                         CAAATCCTGCCCTATCCCTTG                                                                                  
  Bo_bi_rpoB_P                                                         AAAGTCCTCCCGGCCCAAGAGCATTAA                                                                            
  *Borrelia theileri*                                                  glpQ                                Bo_th_glpQ_F            GTGCTAACAAAGGACAATATTCC      213           Plasmid
  Bo_th_glpQ_R                                                         GGTTAGTGGAAAACGGTTAGGAT                                                                                
  Bo_th_glpQ_P                                                         TATTATAATTCACGAGCCAGAGCTTGACAC                                                                         
  *Bartonella* spp.                                                    ssrA                                Bart_spp_ssrA_F         CGTTATCGGGCTAAATGAGTAG       118           \*\*, Culture of *B. quintana*
  Bart_spp_ssrA_R                                                      ACCCCGCTTAAACCTGCGA                                                                                    
  Bart_spp_ssrA_P                                                      TTGCAAATGACAACTATGCGGAAGCACGTC                                                                         
  *Bartonella barcilliformis \**                                       rpoB                                Ba_ba_rpoB_F            GAAGAGTTTGTAGTTTGTCGTCA      105           Culture
  Ba_ba_rpoB_R                                                         AGCAGCTACAGAAACCAACTG                                                                                  
  Ba_ba_rpoB_P                                                         TGCAGGTGAAGTTTTGATGGTGCCACG                                                                            
  *Bartonella henselae*                                                ribC                                Bar_he_ribC_F           GGGATGCGATTTAATAGTTCTAC      116           Culture
  Bar_he_ribC_R                                                        CGCTTGTTGTTTTGATCCTCG                                                                                  
  Bar_he_ribC_P                                                        ACGTTATAGTAGCGAAAACTTAGAAATTGGTGC                                                                      
  *Bartonella vinsonii* subsp. *berkhoffii*                            ITS                                 Bar_vin_ITS_F           GGAATTGCTTAACCCACTGTTG       141           Culture
  Bar_vin_ITS_R                                                        CCTTATTGATTTAGATCTGATGGG                                                                               
  Bar_vin_ITS_P2                                                       AGAAACTCCCGCCTTTATGAGAGAAATCTCT                                                                        
  *Coxiella burnetii* and *Coxiella*-like \*                           Icd                                 Co_bu_icd_F             AGGCCCGTCCGTTATTTTACG        74            Culture
  Co_bu_icd_R                                                          CGGAAAATCACCATATTCACCTT                                                                                
  Co_bu_icd_P                                                          TTCAGGCGTTTTGACCGGGCTTGGC                                                                              
  IS1111                                                               Co_bu_IS111_F                       TGGAGGAGCGAACCATTGGT    86                           Culture       
  Co_bu_IS111_R                                                        CATACGGTTTGACGTGCTGC                                                                                   
  Co_bu_IS111_P                                                        ATCGGACGTTTATGGGGATGGGTATCC                                                                            
  *Francisella tularensis* and *Francisella*-like *endosymbionts* \*   tul4                                Fr_tu_tul4_F            ACCCACAAGGAAGTGTAAGATTA      76            Culture
  Fr_tu_tul4_R                                                         GTAATTGGGAAGCTTGTATCATG                                                                                
  Fr_tu_tul4_P                                                         AATGGCAGGCTCCAGAAGGTTCTAAGT                                                                            
  fopA                                                                 Fr_tu_fopA_F                        GGCAAATCTAGCAGGTCAAGC   91                           Culture       
  Fr_tu_fopA_R                                                         CAACACTTGCTTGAACATTTCTAG                                                                               
  Fr_tu_fopA_P                                                         AACAGGTGCTTGGGATGTGGGTGGTG                                                                             
  *Anaplasma* spp.                                                     16S rRNA                            Ana_spp_16S_F           CTTAGGGTTGTAAAACTCTTTCAG     160           \*\*
  Ana_spp_16S_R                                                        CTTTAACTTACCAAACCGCCTAC                                                                                
  Ana_spp_16S_P                                                        ATGCCCTTTACGCCCAATAATTCCGAACA                                                                          
  *Anaplasma marginale \**                                             msp1b                               An_ma_msp1_F            CAGGCTTCAAGCGTACAGTG         85            Experimentally infected bovine blood sample
  An_ma_msp1_R                                                         GATATCTGTGCCTGGCCTTC                                                                                   
  An_ma_msp1_P                                                         ATGAAAGCCTGGAGATGTTAGACCGAG                                                                            
  *Anaplasma phagocytophilum \**                                       msp2                                An_ph_msp2_F            GCTATGGAAGGCAGTGTTGG         77            Infected *Ixodes* spp. tick
  An_ph_msp2_R                                                         GTCTTGAAGCGCTCGTAACC                                                                                   
  An_ph_msp2_P                                                         AATCTCAAGCTCAACCCTGGCACCAC                                                                             
  *Anaplasma platys \**                                                groEL                               An_pla_groEL_F          TTCTGCCGATCCTTGAAAACG        75            Infected canine blood sample
  An_pla_groEL_R                                                       CTTCTCCTTCTACATCCTCAG                                                                                  
  An_pla_groEL_P                                                       TTGCTAGATCCGGCAGGCCTCTGC                                                                               
  *Anaplasma bovis \**                                                 groEL                               An_bo_groEL_F           GGGAGATAGTACACATCCTTG        73            Plasmid
  An_bo_groEL_R                                                        CTGATAGCTACAGTTAAGCCC                                                                                  
  An_bo_groEL_P                                                        AGGTGCTGTTGGATGTACTGCTGGACC                                                                            
  *Anaplasma ovis \**                                                  msp4                                An_ov_msp4_F            TCATTCGACATGCGTGAGTCA        92            Plasmid
  An_ov_msp4_r                                                         TTTGCTGGCGCACTCACATC                                                                                   
  An_ov_msp4_P                                                         AGCAGAGAGACCTCGTATGTTAGAGGC                                                                            
  *Ehrlichia* spp. *\**                                                16S rRNA                            Neo_mik_16S_F           GCAACGCGAAAAACCTTACCA        98            \*\*
  Neo_mik_16S_R                                                        AGCCATGCAGCACCTGTGT                                                                                    
  Neo_mik_16S_P                                                        AAGGTCCAGCCAAACTGACTCTTCCG                                                                             
  *Ehrlichia canis*                                                    gltA                                Eh_ca_gltA_F            GACCAAGCAGTTGATAAAGATGG      136           Culture
  Eh_ca_gltA_R                                                         CACTATAAGACAATCCATGATTAGG                                                                              
  Eh_ca_gltA_P                                                         ATTAAAACATCCTAAGATAGCAGTGGCTAAGG                                                                       
  *Ehrlichia chaffeensis \**                                           dsb                                 Eh_ch_dsb_F             TATTGCTAATTACCCTCAAAAAGTC    117           Infected *Amblyomma americanum*
  Eh_ch_dsb_R                                                          GAGCTATCCTCAAGTTCAGATTT                                                                                
  Eh_ch_dsb_P                                                          ATTGACCTCCTAACTAGAGGGCAAGCA                                                                            
  *Ehrlichia ewingii \**                                               dsb                                 Eh_ew_dsb_F             CAATACTTGGAGAAGCATCATTG      111           Infected *Amblyomma americanum*
  Eh_ew_dsb_R                                                          TTGCTTATGGCTTAATGCTGCAT                                                                                
  Eh_ew_dsb_P                                                          AAAGCAGTACGTGCAGCATTGGCTGTA                                                                            
  *Ehrlichia ruminantium*                                              gltA                                Eh_ru_gltA_F            CCAGAAAACTGATGGTGAGTTAG      116           Culture
  Eh_ru_gltA_R                                                         AGCCTACATCAGCTTGAATGAAG                                                                                
  Eh_ru_gltA_P                                                         AGTGTAAACTTGCTGTTGCTAAGGTAGCATG                                                                        
  Panola Mountain *Ehrlichia*                                          gltA                                Eh_PME_gltA_F           GCTAGTTATGAGTTAGAATGTAAAC    121           Infected *Amblyomma americanum*
  Eh_PME_gltA_R                                                        TACTATAGGATAATCTTGAATCAGC                                                                              
  Eh_PME_gltA_P                                                        TTGCTATCGCTAAAATTCCAAGTATGATTGCG                                                                       
  *Neoehrlichia mikurensis \**                                         groEL                               Neo_mik_groEL_F         AGAGACATCATTCGCATTTTGGA      96            Infected rodent blood sample
  Neo_mik_groEL_R                                                      TTCCGGTGTACCATAAGGCTT                                                                                  
  Neo_mik_groEL_P                                                      AGATGCTGTTGGATGTACTGCTGGACC                                                                            
  *Aegyptianella pullorum*                                             groEL                               Ae_pul_groEL_F          AGCCAGTATTATCGCTCAAGG        168           Plasmid
  Ae_pul_groEL_R                                                       GCCTCACGTGCCTTCATAAC                                                                                   
  Ae_pul_groEL_P                                                       TGCTTCTCAGTGTAACGACAGGGTTGG                                                                            
  *Apicomplexa*                                                        18S rRNA                            Apic_18S_F              TGAACGAGGAATGCCTAGTATG       104           \*\*, Infected canine blood sample, with *B. canis rossi, B. canis canis*; Culture of *B. divergens, T. lestoquari, T. annulata*
  Apic_18S_R                                                           CACCGGATCACTCGATCGG                                                                                    
  Apic_18S_S                                                           TAGGAGCGACGGGCGGTGTGTAC                                                                                
  *Babesia canis vogeli \**                                            hsp70                               Ba_vo_hsp70_F           TCACTGTGCCTGCGTACTTC         87            Infected canine blood sample
  Ba_vo_hsp70_R                                                        TGATACGCATGACGTTGAGAC                                                                                  
  Ba_vo_hsp70_P                                                        AACGACTCCCAGCGCCAGGCCAC                                                                                
  *Babesia ovis \**                                                    18S rRNA                            Ba_ov_18S_F             TCTGTGATGCCCTTAGATGTC        92            Plasmid
  Ba_ov_18S_R                                                          GCTGGTTACCCGCGCCTT                                                                                     
  Ba_ov_18S_P                                                          TCGGAGCGGGGTCAACTCGATGCAT                                                                              
  *Babesia bigemina \**                                                18S rRNA                            Ba_big_RNA18S_F         ATTCCGTTAACGAACGAGACC        99            Plasmid
  Ba_big_RNA18S_R                                                      TTCCCCCACGCTTGAAGCA                                                                                    
  Ba_big_RNA18S_P                                                      CAGGAGTCCCTCTAAGAAGCAAACGAG                                                                            
  *Babesia gibsoni*                                                    Rap1                                Ba_gib_rap1_F           CTCTTGCTCATCATCTTTTCGG       130           Plasmid
  Ba_gib_rap1_R                                                        TCAGCGTATCCATCCATTATATG                                                                                
  Ba_gib_rap1_S                                                        TTTAATGCGTGCTACGTTGTACTTCCCAAAG                                                                        
  *Babesia caballi \**                                                 Rap1                                Ba_cab_rap1_F           GTTGTTCGGCTGGGGCATC          94            Plasmid
  Ba_cab_rap1_R                                                        CAGGCGACTGACGCTGTGT                                                                                    
  Ba_cab_rap1_P                                                        TCTGTCCCGATGTCAAGGGGCAGGT                                                                              
  *Babesia bovis \**                                                   CCTeta                              Ba_bo_CCTeta_F          GCCAAGTAGTGGTAGACTGTA        100           Plasmid
  Ba_bo_CCTeta_R                                                       GCTCCGTCATTGGTTATGGTA                                                                                  
  Ba_bo_CCTeta_P                                                       TAAAGACAACACTGGGTCCGCGTGG                                                                              
  *Babesia duncani \**                                                 ITS2                                Ba_du_ITS_F             ATTTCCGTTTGCGAGAGTTGC        87            Plasmid
  Ba_du_ITS_R                                                          AGGAAGCATCAAGTCATAACAAC                                                                                
  Ba_du_ITS_P                                                          AACAAGAGGCCCCGAGATCAAGGCAA                                                                             
  *Babesia microti \**                                                 CCTeta                              Bab_mi_CCTeta_F         ACAATGGATTTTCCCCAGCAAAA      145           Culture
  Bab_mi_CCTeta_R                                                      GCGACATTTCGGCAACTTATATA                                                                                
  Bab_mi_CCTeta_P                                                      TACTCTGGTGCAATGAGCGTATGGGTA                                                                            
  *Theileria parva \**                                                 18S rRNA                            Th_pa_18S_F             GAGTATCAATTGGAGGGCAAG        173           Culture
  Th_pa_18S_R                                                          CAGACAAAGCGAACTCCGTC                                                                                   
  Th_pa_18S_P                                                          AAATAAGCCACATGCAGAGACCCCGAA                                                                            
  *Theileria mutans*                                                   ITS                                 The_mu_ITS_F            CCTTATTAGGGGCTACCGTG         119           Plasmid
  The_mu_ITS_R                                                         GTTTCAAATTTGAAGTAACCAAGTG                                                                              
  The_mu_ITS_P                                                         ATCCGTGAAAAACGTGCCAAACTGGTTAC                                                                          
  *Theileria velifera*                                                 18S rRNA                            The_ve_18S_F            TGTGGCTTATCTGGGTTCGC         151           Plasmid
  The_ve_18S_R                                                         CCATTACTTTGGTACCTAAAACC                                                                                
  The_ve_18S_P                                                         TTGCGTTCCCGGTGTTTTACTTTGAGAAAG                                                                         
  *Theileria equi*                                                     ema1                                Th_eq_ema1_F4           CGGCAAGAAGCACACCTTC          167           Plasmid
  Th_eq_ema1_R4                                                        TGCCATCGCCCTTGTAGAG                                                                                    
  Th_eq_ema1_P4                                                        AAGGCTCCAGGCAAGCGCGTCCT                                                                                
  *Cytauxzoon felis*                                                   ITS2                                Cy_fel_ITS2_F           AAGATCCGAACGGAGTGAGG         119           Plasmid
  Cy_fel_ITS2_R                                                        GTAGTCTCACCCAATTTCAGG                                                                                  
  Cy_fel_ITS2_S                                                        AAGTGTGGGATGTACCGACGTGTGAG                                                                             
  *Hepatozoon* spp.                                                    18S rRNA                            Hepa_spp_18S_F          ATTGGCTTACCGTGGCAGTG         175           \*\*
  Hepa_spp_18S_R                                                       AAAGCATTTTAACTGCCTTGTATTG                                                                              
  Hepa_spp_18S_S                                                       ACGGTTAACGGGGGATTAGGGTTCGAT                                                                            
  *Hepatozoon canis*                                                   18S rRNA                            He_can_18S_F            TTCTAACAGTTTGAGAGAGGTAG      221           Infected canine blood sample
  He_can_18S_R                                                         AGCAGACCGGTTACTTTTAGC                                                                                  
  He_can_18S_S                                                         AGAACTTCAACTACGAGCTTTTTAACTGCAAC                                                                       
  *Hepatozoon americanum*                                              18S rRNA                            He_ame_18S_F2           GGTATCATTTTGGTGTGTTTTTAAC    159           Plasmid
  He_ame_18S_R2                                                        CTTATTATTCCATGCTCCAGTATTC                                                                              
  He_ame_18S_P2                                                        AAAAGCGTAAAAGCCTGCTAAAAACACTCTAC                                                                       
  *Leishmania* spp.                                                    hsp70                               Leish_spp_hsp70_F       CGACCTGTTCCGCAGCAC           78            \*\* and culture of *L. martiniquensis*
  Leish_spp_hsp70_R                                                    TCGTGCACGGAGCGCTTG                                                                                     
  Leish_spp_hsp70_S                                                    TCCATCTTCGCGTCCTGCAGCACG                                                                               
  *Leishmania infantum*                                                ITS                                 Le_inf_ITS_F            CGCACCGCCTATACAAAAGC         103           Culture
  Le_inf_ITS_R                                                         GTTATGTGAGCCGTTATCCAC                                                                                  
  Le_inf_ITS_S                                                         ACACGCACCCACCCCGCCAAAAAC                                                                               
  *Rangelia vitalii*                                                   18S rRNA                            Ra_vit_18S_F            TAACCGTGCTAATTGTAGGGC        92            Plasmid
  Ra_vit_18S_R                                                         GAATCACCAAACCAAATGGAGG                                                                                 
  Ra_vit_18S_S                                                         TAATACACGTTCGAGGGCGCGTTTTGC                                                                            
  *Tick* spp.                                                          16S rRNA                            Tick_spp_16S_F          AAATACTCTAGGGATAACAGCGT      99            \*\*
  Tick_spp_16S_R                                                       TCTTCATCAAACAAGTATCCTAATC                                                                              
  Tick_spp_16S_P                                                       CAACATCGAGGTCGCAAACCATTTTGTCTA                                                                         
  *Amblyomma variegatum*                                               ITS2                                Amb_var_ITS2_F          GCCAGCCTCTGAAGTGACG          117           Tick extract (Guadeloupe)
  Amb_var_ITS2_R                                                       TTCTGCGGTTTAAGCGACGC                                                                                   
  Amb_var_ITS2_P                                                       TCTTGCCACTCGACCCGTGCCTC                                                                                
  *Rhipicephalus microplus*                                            ITS2                                Rhi_mic_ITS2_F          GCTTAAGGCGTTCTCGTCG          144           Tick extract (Galapagos Islands)
  Rhi_mic_ITS2_R                                                       CAAGGGCAGCCACGCAG                                                                                      
  Rhi_mic_ITS2_P                                                       TAGTCCGCCGTCGGTCTAAGTGCTTC                                                                             
  *Rhipicephalus sanguineus* sensu lato                                ITS2                                Rhi_san_ITS2_F          TTGAACGCTACGGCAAAGCG         110           Tick extract (France)
  Rhi_san_ITS2_R                                                       CCATCACCTCGGTGCAGTC                                                                                    
  Rhi_san_ITS2_P                                                       ACAAGGGCCGCTCGAAAGGCGAGA                                                                               
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###### 

Homology between the deposited sequences and reference sequences in GenBank (T: Sample number tested by conventional assay; S: Sample number which allowed sequence recovery; AN: Accession number of the recovered sequence; L: recovered sequence length (bp); Id%: percentage of nucleotide identity between recovered and reference sequences).

  Biomark Id                Sequence Name                         T    S    AN         L     Closest Homology                    Id%   Reference
  ------------------------- ------------------------------------- ---- ---- ---------- ----- ----------------------------------- ----- -------------
  *Rickettsia* spp.         *Rickettsia africae* Tick208          30   14   MK049851   248   *Rickettsia africae*                100   AF123706.1
  *Leishmania* spp.         *Leishmania martiniquensis* Tick389   2    1    MK049850   272   *Leishmania martiniquensis*         100   AF303938.1
                                                                                             *Leishmania siamensis*              100   GQ226033.1
  *Borrelia* spp.           *Borrelia* sp. Tick7                  30   1    MK049846   245   *Borrelia anserina*                 90    X75201.1
                            *Borrelia* sp. Tick457                     4    MK049847   327   *Borrelia* sp. BR                   100   EF141022.1
                                                                                             *Borrelia* sp. strain Mo063b-flaB   100   KY070335.1
                                                                                             *Borrelia theileri*                 99    KF569936.1
  *Anaplasma* spp.          *Anaplasma* sp. Tick314               2    2    MK049845   245   *Candidatus* Anaplasma boleense     100   KX987335.1
  *Anaplasma marginale*     *Anaplasma* sp. Tick283               2    2    MK049844   244   *Anaplasma marginale*               100   MH155593.1
                                                                                             *Anaplasma centrale*                100   MF289482.1
                                                                                             *Anaplasma ovis*                    100   MG770440.1
                                                                                             *Anaplasma capra*                   100   MF000917.1
                                                                                             *Anaplasma phagocytophilum*         100   DQ648489.1
  *Ehrlichia* spp.          *Ehrlichia* sp. Tick428               2    2    MK049849   246   *Ehrlichia* spp.                    100   KY594915.1
                                                                                             *Ehrlichia canis*                   99    KY594915.1
                                                                                             *Ehrlichia ewingii*                 99    U96436.1
                                                                                             *Ehrlichia chaffeensis*             99    NR_074500.2
                                                                                             *Ehrlichia muris*                   99    KU535865.1
                                                                                             *Ehrlichia minasensis*              99    NR_148800.1
  *Ehrlichia ruminantium*   *Ehrlichia ruminantium* Tick116       1    1    MK049848   207   *Ehrlichia ruminantium*             100   NR_074155.1
  *Babesia bigemina*        *Babesia bigemina* Tick222            2    1    MK071738   99    *Babesia bigemina*                  100   KP710227.1
  *Babesia bovis*           *Babesia bovis* Tick497               2    2    MK071739   100   *Babesia bovis*                     99    AB367921.1
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###### 

Primers used to confirm the presence of pathogenic DNA in tick samples.

  Pathogen                       Targeted Gene   Primer Name      Sequence (5′ → 3′)              Length (bp)   References
  ------------------------------ --------------- ---------------- ------------------------------- ------------- -------------------------------
  *Rickettsia* spp.              gltA            Rsfg877          GGGGGCCTGCTCACGGCGG             381           \[[@B67-pathogens-09-00176]\]
                                                 Rsfg1258         ATTGCAAAAAGTACAGTGAACA                        
                                 ompB            Rc.rompB.4362p   GTCAGCGTTACTTCTTCGATGC          475           \[[@B68-pathogens-09-00176]\]
                                                 Rc.rompB.4836n   CCGTACTCCATCTTAGCATCAG                        
                                                 Rc.rompB.4496p   CCAATGGCAGGACTTAGCTACT          267           
                                                 Rc.rompB.4762n   AGGCTGGCTGATACACGGAGTAA                       
  *Anaplasma*/*Ehrlichia* spp.   16S rRNA        EHR16SD          GGTACCYACAGAAGAAGTCC            345           \[[@B69-pathogens-09-00176]\]
                                                 EHR16SR          TAGCACTCATCGTTTACAGC                          
  *Borrelia* spp.                flaB            FlaB280F         GCAGTTCARTCAGGTAACGG            645           \[[@B70-pathogens-09-00176]\]
                                                 FlaRL            GCAATCATAGCCATTGCAGATTGT                      
                                                 FlaB737F         GCATCAACTGTRGTTGTAACATTAACAGG   407           
                                                 FlaLL            ACATATTCAGATGCAGACAGAGGT                      
  *Leishmania* spp.              SSU rRNA        R221             GGTTCCTTTCCTGATTTACG            603           \[[@B71-pathogens-09-00176]\]
                                                 R332             GGCCGGTAAAGGCCGAATAG                          
                                                 R223             TCCATCGCAACCTCGGTT              358           
                                                 R333             AAAGCGGGCGCGGTGCTG                            
